Category: KB

  • MIL-OSI: Red White & Bloom Brands Announces New Date for Annual General Meeting

    Source: GlobeNewswire (MIL-OSI)

    TORONTO, June 24, 2025 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) announces that its Annual General Meeting (“AGM”), originally scheduled for Friday, June 27, 2025, has been rescheduled to Friday, July 11, 2025. The change will allow for the completion and filing of the Company’s audited financial statements and accompanying management discussion and analysis for the year-ended December 31, 2024, both of which will be presented at the AGM. The change to the annual general meeting date is permissible in accordance with the record date established for the AGM.

    The AGM will be held at the same time and location as indicated in the proxy materials mailed to shareholders on May 28, 2025, which remain available on SEDAR+ at www.sedarplus.ca and on the Company’s website at: https://ir.redwhitebloom.com/news-events/ir-calendar.

    Voting remains open and shareholders may cast their votes until 8:00 am Pacific Time on Wednesday, July 9, 2025. The Company confirms that no new proxy materials will be issued in connection with the rescheduled AGM, and that the previously distributed proxy materials remain valid for use at the rescheduled meeting.

    About Red White & Bloom Brands Inc.

    Red White & Bloom Brands is a multi-jurisdictional cannabis operator and house of premium brands operating in the United States, Canada and internationally. The Company is predominantly focusing its investments on major U.S. markets, including California, Florida, Missouri, Michigan, and Ohio in addition to Canadian and international markets.

    Red White & Bloom Brands Inc.
    Investor and Media Relations
    Edoardo Mattei, CFO
    IR@RedWhiteBloom.com
    947-225-0503

    Visit us on the web: https://www.redwhitebloom.com/.

    Follow us on social media:

    Twitter @rwbbrands

    Facebook @redwhitebloombrands

    Instagram @redwhitebloombrands

    Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

    FORWARD LOOKING INFORMATION

    Certain information contained in this news release may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian securities legislation. Forward-looking information is often identified by the use of words such as “plans,” “expects,” “may,” “should,” “could,” “will,” “intends,” “anticipates,” “believes,” “estimates,” “forecasts,” or variations of such words and phrases, including the negative forms thereof, as well as terms such as “pro forma” and “scheduled,” and similar expressions that refer to future events or outcomes.

    Forward-looking statements in this release include, without limitation, statements regarding the rescheduled date of the AGM, the anticipated completion and filing of the Company’s audited financial statements and accompanying management’s discussion and analysis, and the timing of shareholder voting.

    Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, delays in the preparation or filing of financial statements; the ability to meet regulatory and stock exchange requirements; market conditions; and other risks relating to the Company’s business and financial condition.

    There can be no assurance that such forward-looking statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

    The Company disclaims any obligation to update or revise any forward-looking information contained herein, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws.

    THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE COMPANY’S EXPECTATIONS AS OF THE DATE OF THIS NEWS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE THE COMPANY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.

    The MIL Network

  • MIL-OSI: Xtract One Selected to Support San Mateo Medical Center in Keeping Patients and Staff Secure

    Source: GlobeNewswire (MIL-OSI)

    TORONTO, June 24, 2025 (GLOBE NEWSWIRE) — Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its SmartGateway has been selected by San Mateo Medical Center, located in San Mateo, CA, to strengthen the facility’s security and provide AI-powered weapon detection. Xtract One’s leading technology-driven threat detection and security solutions are designed to enhance safety for patients, visitors, and staff at the medical center, starting with the main campus with plans to later expand to all satellite clinics.

    This deployment comes at a critical time for healthcare facilities, following California’s recent Assembly Bill (AB) 2975. With hospitals now being required to implement weapons detection screening policies at key entrances as a minimum, San Mateo Medical Center demonstrates its forward-thinking and proactive stance in deploying Xtract One’s cutting-edge technology designed to help elevate safety while enhancing the overall individual experience.

    “With violent incidents being five times more frequent in healthcare facilities than in other industries, we recognize the unique challenge hospitals face in ensuring a safe environment,” said Peter Evans, CEO of Xtract One. “Our SmartGateway has shown proven efficacy in on-site, real-world testing and we are confident that its deployment at San Mateo Medical Center will provide enhanced security that identifies potential threats of all kinds, including firearms and edged weapons, and minimizes disruptions to patients, staff, and visitors. We’re looking forward to working with San Mateo Medical Center and to showcasing how well SmartGateway supports healthcare facilities’ needs.”

    “Our goal is to create a safe and welcoming environment for everyone who enters our facility so that we can focus on what truly matters–our patients’ well-being” said Robet Blake, COO of San Mateo Medical Center. “Deploying Xtract One’s technology at our main campus reinforces that commitment. After extensive testing of various systems, we found SmartGateway’s innovative technology to be the most effective for our facility’s needs, allowing us to stay ahead of potential threats in order to maintain a secure and welcoming campus for everyone.”

    SmartGateway’s breakthrough innovation provides fast, discreet, and reliable individual screening, utilizing AI-powered sensors that unobtrusively scan guests for weapons and other prohibited items as they walk through. This technology replaces traditional metal detectors, reducing the need to empty pockets, optimizing patron experience by reducing time spent in security lines, and providing critical security insights to maximize screening outcomes. SmartGateway is designed to enable seamless passage through checkpoints and promote uninterrupted flow of movement.

    To learn more, visit www.xtractone.com.

    About Xtract One
    Xtract One Technologies is a leading technology-driven provider of threat detection and security solutions leveraging AI to deliver seamless and secure experiences. The Company makes unobtrusive weapons and threat detection systems that are designed to assist facility operators in prioritizing and delivering improved “Walk-right-In” experiences while enhancing safety. Xtract One’s innovative portfolio of AI-powered Gateway solutions excels at allowing facilities to discreetly screen and identify weapons and other threats at points of entry and exit without disrupting the flow of traffic. With solutions built to serve the unique market needs for schools, hospitals, arenas, stadiums, manufacturing, distribution, and other customers, Xtract One is recognized as a market leader delivering the highest security in combination with the best individual experience. For more information, visit www.xtractone.com or connect on Facebook, X, and LinkedIn.

    About San Mateo Medical Center
    San Mateo Medical Center is a public hospital and clinic system fully accredited by The Joint Commission. We operate outpatient clinics throughout the county and an acute-care hospital in San Mateo. Our mission is to “partner with our community to provide excellent healthcare for patients, including those experiencing social, environmental, or economic challenges.” As part of San Mateo County Health, the medical center serves the healthcare needs of all residents of San Mateo County, with an emphasis on education and prevention.

    About Threat Detection and Security Solutions
    Xtract One solutions, when properly configured, deployed, and utilized, are designed to help enhance safety and reduce threats. Given the wide range of potential threats in today’s world, no threat detection system is 100% effective. Xtract One solutions should be utilized as one element in a multilayered approach to physical security.

    Forward Looking Statements
    This news release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”. Forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. Such risks and uncertainties include, but are not limited to, the risks detailed from time to time in the continuous disclosure filings made by the Company with securities regulations. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although the Company has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company has no obligation to update any forward looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

    For further information, please contact:
    Xtract One Inquiries: info@xtractone.com, http://www.xtractone.com   
    Investor Relations: Chris Witty, Darrow Associates, cwitty@darrowir.com, 646-438-9385
    Media Contact: Kristen Aikey, JMG Public Relations, kristen@jmgpr.com, 212-206-1645

    The MIL Network

  • MIL-OSI: Xtract One Selected to Support San Mateo Medical Center in Keeping Patients and Staff Secure

    Source: GlobeNewswire (MIL-OSI)

    TORONTO, June 24, 2025 (GLOBE NEWSWIRE) — Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its SmartGateway has been selected by San Mateo Medical Center, located in San Mateo, CA, to strengthen the facility’s security and provide AI-powered weapon detection. Xtract One’s leading technology-driven threat detection and security solutions are designed to enhance safety for patients, visitors, and staff at the medical center, starting with the main campus with plans to later expand to all satellite clinics.

    This deployment comes at a critical time for healthcare facilities, following California’s recent Assembly Bill (AB) 2975. With hospitals now being required to implement weapons detection screening policies at key entrances as a minimum, San Mateo Medical Center demonstrates its forward-thinking and proactive stance in deploying Xtract One’s cutting-edge technology designed to help elevate safety while enhancing the overall individual experience.

    “With violent incidents being five times more frequent in healthcare facilities than in other industries, we recognize the unique challenge hospitals face in ensuring a safe environment,” said Peter Evans, CEO of Xtract One. “Our SmartGateway has shown proven efficacy in on-site, real-world testing and we are confident that its deployment at San Mateo Medical Center will provide enhanced security that identifies potential threats of all kinds, including firearms and edged weapons, and minimizes disruptions to patients, staff, and visitors. We’re looking forward to working with San Mateo Medical Center and to showcasing how well SmartGateway supports healthcare facilities’ needs.”

    “Our goal is to create a safe and welcoming environment for everyone who enters our facility so that we can focus on what truly matters–our patients’ well-being” said Robet Blake, COO of San Mateo Medical Center. “Deploying Xtract One’s technology at our main campus reinforces that commitment. After extensive testing of various systems, we found SmartGateway’s innovative technology to be the most effective for our facility’s needs, allowing us to stay ahead of potential threats in order to maintain a secure and welcoming campus for everyone.”

    SmartGateway’s breakthrough innovation provides fast, discreet, and reliable individual screening, utilizing AI-powered sensors that unobtrusively scan guests for weapons and other prohibited items as they walk through. This technology replaces traditional metal detectors, reducing the need to empty pockets, optimizing patron experience by reducing time spent in security lines, and providing critical security insights to maximize screening outcomes. SmartGateway is designed to enable seamless passage through checkpoints and promote uninterrupted flow of movement.

    To learn more, visit www.xtractone.com.

    About Xtract One
    Xtract One Technologies is a leading technology-driven provider of threat detection and security solutions leveraging AI to deliver seamless and secure experiences. The Company makes unobtrusive weapons and threat detection systems that are designed to assist facility operators in prioritizing and delivering improved “Walk-right-In” experiences while enhancing safety. Xtract One’s innovative portfolio of AI-powered Gateway solutions excels at allowing facilities to discreetly screen and identify weapons and other threats at points of entry and exit without disrupting the flow of traffic. With solutions built to serve the unique market needs for schools, hospitals, arenas, stadiums, manufacturing, distribution, and other customers, Xtract One is recognized as a market leader delivering the highest security in combination with the best individual experience. For more information, visit www.xtractone.com or connect on Facebook, X, and LinkedIn.

    About San Mateo Medical Center
    San Mateo Medical Center is a public hospital and clinic system fully accredited by The Joint Commission. We operate outpatient clinics throughout the county and an acute-care hospital in San Mateo. Our mission is to “partner with our community to provide excellent healthcare for patients, including those experiencing social, environmental, or economic challenges.” As part of San Mateo County Health, the medical center serves the healthcare needs of all residents of San Mateo County, with an emphasis on education and prevention.

    About Threat Detection and Security Solutions
    Xtract One solutions, when properly configured, deployed, and utilized, are designed to help enhance safety and reduce threats. Given the wide range of potential threats in today’s world, no threat detection system is 100% effective. Xtract One solutions should be utilized as one element in a multilayered approach to physical security.

    Forward Looking Statements
    This news release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”. Forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. Such risks and uncertainties include, but are not limited to, the risks detailed from time to time in the continuous disclosure filings made by the Company with securities regulations. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although the Company has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company has no obligation to update any forward looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

    For further information, please contact:
    Xtract One Inquiries: info@xtractone.com, http://www.xtractone.com   
    Investor Relations: Chris Witty, Darrow Associates, cwitty@darrowir.com, 646-438-9385
    Media Contact: Kristen Aikey, JMG Public Relations, kristen@jmgpr.com, 212-206-1645

    The MIL Network

  • MIL-OSI: Addressing Surging Demand, Vetty Reports Strong Growth, Strategic Wins and Expanded Integrations in 1H 2025

    Source: GlobeNewswire (MIL-OSI)

    AUSTIN, Texas, June 24, 2025 (GLOBE NEWSWIRE) — Seeing a 22.4 percent increase in revenue year over year, Vetty, the one-stop shop hiring acceleration platform, has continued to build on its momentum in the first half of 2025. On pace to surpass its June goals, the company exceeded monthly targets from January to May, reinforcing Vetty’s value in a rapidly evolving market.

    “2025 is proving to be a defining year for Vetty,” said CEO Jason Putnam. “We’re scaling revenue while transforming our leadership team, operations and partnerships to deliver faster, smarter and more agile solutions to our customers.”

    Market Outlook Drives Demand
    Since January, a degree of caution has dominated workforce decision-making, with employers seeking solutions able to accelerate time-to-hire without compromising compliance or candidate experience. Organizations are looking for cost-effective, risk-averse technologies that can streamline hiring processes by augmenting existing systems. Vetty meets these demands with its easily integrated platform that eliminates manual inefficiencies through high-speed, high-compliance workflows for screening and onboarding.

    In this complex and competitive market, Vetty has differentiated itself through numerous strategic initiatives, including:

    • Team Updates: Vetty has appointed Jason Putnam as CEO and Michelle Meehan as Chief Marketing Officer, with Sumanth Channabasappa in charge of Product and Technology. Jennifer Aichele decided to join the company full-time as Chief Financial Officer after completing a fractional assignment. Gregg Moran has signed on to oversee Partnerships, and Roger Dowie and Katrina Polansky have joined on the sales side. Vikrant Viniak was recently named to the company’s board. These fresh voices have brought considerable expertise to the company, driving significant accomplishments in only a few short months.
    • Deeper Integrations and New Partnerships: In 1H 2025, Vetty established partnerships with Bullhorn and Walton Management, expanded its collaboration with Chattr and started building alliances with key system integrators to strengthen its HR technology ecosystem. At the same time, expanded ATS integrations have enabled faster candidate-to-active workflows, supporting Vetty’s accelerated growth in the enterprise.
    • Relentless Innovation: Along with these integrations, Vetty introduced several key enhancements, notably faster, more customizable health screening orders alongside background checks (a standout capability for the industry); automation to improve turnaround times; enhanced progress monitoring; and improved fraud detection using integrated identity verification offerings, further demonstrating the company’s commitment to compliance and operational excellence.
    • Customer Wins: Vetty signed significant new business relationships across several key verticals, including healthcare and healthcare staffing, traditional staffing and high-volume hiring. Representing the company’s growing footprint and measurable impact are:
      • A major healthcare staffing provider with an optimized onboarding process reduced its time to active positive to under five days.
      • A traditional staffing firm that now manages placements from a single platform can fill roles in under four days.
      • Three elder care, nursing and rehab companies, which collectively manage 100 facilities, have digitized state licensing requirements, transforming a paper-based process into a compliant and automated system.

    Looking Ahead: Forecasting Continued Velocity
    Having achieved substantial milestones in the first half of 2025, Vetty intends to stay on its current course moving into the second half of the year. The company’s plans include continued revenue outperformance, developing additional ATS integrations and partnerships, fostering an enviable company culture and fueling product and customer success. To date, these moves have prompted several enterprise wins and record-high participation in key satisfaction metrics, such as USAT surveys.

    Putnam shared, “Over the last few months, we’ve set a strong foundation for Vetty’s next phase of growth. Moving quickly but thoughtfully, what we’ve created is a testament to what Vetty offers – a modern, proactive and valuable solution that makes it possible to win the hiring game.”

    ABOUT VETTY
    Vetty is a one-stop shop hiring acceleration platform where companies can expeditiously complete their screening, credentialing, hiring and onboarding of prospective candidates. Companies count on Vetty to accelerate the time from offer to active and deliver clearly measurable ROI. Learn more at https://vetty.co.

    The MIL Network

  • MIL-OSI: iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results

    Source: GlobeNewswire (MIL-OSI)

    Lead amylin receptor agonist engineered antibody significantly reduced acute food intake in a mouse model of obesity, comparable to the efficacy of a leading amylin peptide agonist

    Findings support the potential of antibody-based agonists to address the growing demand for safer, longer-acting treatments for obesity and cardiometabolic diseases

    Conference call today, June 24 at 8:30 a.m. ET to discuss new pre-clinical data and obesity pipeline

    SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) — iBio, Inc. (Nasdaq: IBIO), an AI-driven innovator of next-generation antibody therapies, today announced preclinical data in which an engineered amylin receptor agonist antibody reduced acute food intake in a mouse model of obesity by 60% (p<0.05), equivalent to the reduction in food intake from a clinically advanced dual amylin and calcitonin receptor agonist (DACRA) peptide (67%). The effect on food intake was monitored over various time points in this side-by-side study with the amylin agonist iBio discovered and a DACRA peptide. The study marks the third target to emerge from iBio’s partnership with AstralBio.

    The successful iBio-AstralBio collaboration now includes multiple novel engineered antibody agonists with a wide range of profiles targeting the amylin receptor, a heterodimeric G protein-coupled receptor (GPCR).

    “Emerging clinical data suggest selective activation of the amylin receptor—rather than dual agonism of the amylin and calcitonin receptors—can match or even exceed DACRA efficacy, with improved tolerability,” said Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer of iBio. “Our AI-enabled antibody discovery platform allows us to precisely dial in that selectivity and specifically target the amylin receptor and even its subtypes. This new program underscores iBio’s commitment to developing next-generation therapies to address the limitations of current treatments in the fast-growing obesity market.”

    Amylin, or islet amyloid polypeptide (IAPP), is a pancreatic B-cell hormone shown to regulate satiety and delay gastric emptying. When activated through receptor agonism, it enhances meal-ending metabolic signals that prolong the feeling of fullness. Amylin receptors (AMYRs), composed of heterodimeric GPCRs, represent a compelling therapeutic target for obesity and other cardiometabolic diseases. iBio’s approach leverages its proprietary Drug Discovery Platform and advanced AI platform to discover innovative antibodies with exceptional selectivity and potency. This allowed the discovery of molecules capable of agonizing a single AMYR subtype or having balanced agonism at multiple receptors (i.e., DACRA-like agonism profile). This precise and versatile GPCR agonist discovery is thought to allow the identification of a best-in-class therapeutic candidate for an optimal profile of quality weight loss, gastrointestinal tolerability, and lean mass preservation.

    Other amylin analogs currently under clinical development have achieved reduced body weight in obese patients of up to 22.7%1 when used in combination with semaglutide and 11.8%2 as monotherapy. By targeting a different set of signaling pathways, this novel approach holds promise not only for enhancing the weight-loss efficacy seen with GLP-1 receptor agonists but also as a monotherapy option for patients who are intolerant or insufficiently responsive to GLP-1-based interventions.

    References

    1. https://www.hcplive.com/view/cagrisema-achieves-22-7-weight-loss-in-phase-3-redefine-1-trial

    2. https://www.biopharmadive.com/news/novo-nordisk-cagrisema-study-results-diabetes-weight-loss/742008/

    Conference Call Details

    iBio will host a conference call today, June 24, at 8:30 a.m. ET to discuss new pre-clinical data and the Company’s obesity pipeline.

    The webcast of the live call may be accessed on the Investors section of the iBio website at ir.ibioinc.com/news-events/ir-calendar. A replay of the webcast will be available on the iBio website for approximately 60 days following the presentation.

    To join the live call, participants need to access this link for dial-in numbers and a unique participation code.

    About iBio, Inc.

    iBio (Nasdaq: IBIO) is a cutting-edge biotech company leveraging AI and advanced computational biology to develop next-generation biopharmaceuticals for cardiometabolic diseases, obesity, cancer and other hard-to-treat diseases. By combining proprietary 3D modeling with innovative drug discovery platforms, iBio is creating a pipeline of breakthrough antibody treatments to address significant unmet medical needs. Our mission is to transform drug discovery, accelerate development timelines, and unlock new possibilities in precision medicine. For more information, visit www.ibioinc.com or follow us on LinkedIn.

    Forward-Looking Statements

    Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. These forward-looking statements are based upon current estimates and assumptions and include statements regarding the potential of antibody-based agonists to address the growing demand for safer, longer-acting treatments for obesity and cardiometabolic diseases, accelerating the development of novel antibodies for obesity and cardiometabolic diseases in partnership with AstralBio Inc., the positive early results supporting iBio’s approach to antibody-based amylin receptor agonism for the treatment of obesity, iBio’s engineered antibody potentially offering differentiated advantages in dosing and tolerability, developing next-generation therapies to address the limitations of current treatments in the fast-growing obesity market, leveraging iBio’s proprietary Drug Discovery Platform and advanced AI platform to discover innovative antibodies with exceptional selectivity and potency and iBio’s approach targeting the amylin receptor holding promise not only for enhancing the weight-loss efficacy seen with GLP-1 receptor agonists but also as a monotherapy option for patients who are intolerant or insufficiently responsive to GLP-1-based interventions. While iBio believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are subject to various risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, the ability of amylin receptor to be a successful target for obesity and cardiometabolic diseases; iBio’s ability to obtain regulatory approvals for commercialization of its product candidates, or to comply with ongoing regulatory requirements; regulatory limitations relating to iBio’s ability to promote or commercialize its product candidates for specific indications; acceptance of iBio’s product candidates in the marketplace and the successful development, marketing or sale of products; and whether iBio will incur unforeseen expenses or liabilities or other market factors; and the other factors discussed in iBio’s filings with the SEC including its Annual Report on Form 10-K for the year ended June 30, 2024 and its subsequent filings with the SEC on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and iBio undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

    Corporate Contact:
    iBio, Inc.
    Investor Relations
    ir@ibioinc.com

    Media Contacts:
    Ignacio Guerrero-Ros, Ph.D., or David Schull
    Russo Partners, LLC
    Ignacio.guerrero-ros@russopartnersllc.com
    David.schull@russopartnersllc.com
    (858) 717-2310 or (646) 942-5604

    The MIL Network

  • MIL-OSI: Microchip Enhances TrustMANAGER Platform to Support CRA Compliance and Cybersecurity Regulations

    Source: GlobeNewswire (MIL-OSI)

    CHANDLER, Ariz., June 24, 2025 (GLOBE NEWSWIRE) — International cybersecurity regulations continue to adapt to meet the evolving threat landscape. One major focus is on outdated firmware in IoT devices, which can present significant security vulnerabilities. To address these challenges, Microchip Technology (Nasdaq: MCHP) is enhancing its TrustMANAGER platform to include secure code signing and Firmware Over-the-Air (FOTA) update delivery as well as remote management of firmware images, cryptographic keys and digital certificates. These advancements support compliance with the European Cyber Resilience Act (CRA) which mandates strong cybersecurity measures for digital products sold in the European Union (EU). Aligned with standards like the European Telecommunications Standards Institute (ETSI) EN 303 645 baseline requirements of cybersecurity for consumer IoT and the International Society of Automation (ISA)/International Electrotechnical Commission (IEC) 62443 security of industrial automation and control systems standards, the CRA sets a precedent that is expected to influence regulations worldwide.

    Microchip’s ECC608 TrustMANAGER leverages Kudelski IoT’s keySTREAM™ Software as a Service (SaaS) to deliver a secure authentication Integrated Circuit (IC) that is designed to store, protect and manage cryptographic keys and certificates. With the addition of FOTA services, the platform helps customers securely deploy real-time firmware updates to remotely patch vulnerabilities and comply with cybersecurity regulations.

    “As evolving cybersecurity regulations require connected device manufacturers to prioritize the implementation of mechanisms for secure firmware updates, lifecycle credential management and effective fleet deployment,” said Nuri Dagdeviren, corporate vice president of Microchip’s security products business unit. “The addition of FOTA services to Microchip’s TrustMANAGER platform offers a scalable solution that removes the need for manual, and expensive, static infrastructure security updates. FOTA updates allow customers to save resources while fulfilling compliance requirements and helping to future-proof their products against emerging threats and evolving regulations.”

    Further enhancing cybersecurity compliance, the Microchip WINCS02PC Wi-Fi® network controller module used in the TrustMANAGER development kit is now certified against the Radio Equipment Directive (RED) for secure and reliable cloud connectivity. RED establishes strict standards for radio devices in the EU, focusing on network security, data protection and fraud prevention. Beginning August 1, 2025, all wireless devices sold in the EU market must adhere to RED cybersecurity provisions.

    By incorporating these additional services, TrustMANAGER—governed by keySTREAM—tackles key challenges with IoT security, regulatory compliance, device lifecycle management and fleet management. This solution is designed to serve IoT device manufacturers and industrial automation providers. Visit the website to learn more about Microchip’s Trust Platform.

    Development Tools
    The ECC608 TrustMANAGER is compatible with the MPLAB® X Integrated Development Environment (IDE) and supported by Microchip’s CryptoAuth PRO development board (EV89U05A) and the CryptoAuthLib software library. The Trust Platform Design Suite (TPDS) contains a use case example including onboarding educational steps and a firmware code example to enable the keySTREAM service to AWS® with the ECC608 secure element running on a 32-bit Arm® Cortex®-M4-based PIC32CX SG41MCU and a WINCS02PC Wi-Fi module.  

    Pricing and Availability
    You can purchase directly from Microchip or contact a Microchip sales representative or authorized worldwide distributor.

    Resources
    High-res images available through Flickr or editorial contact (feel free to publish):

    About Microchip Technology:
    Microchip Technology Inc. is a leading provider of smart, connected and secure embedded control and processing solutions. Its easy-to-use development tools and comprehensive product portfolio enable customers to create optimal designs which reduce risk while lowering total system cost and time to market. The company’s solutions serve over 100,000 customers across the industrial, automotive, consumer, aerospace and defense, communications and computing markets. Headquartered in Chandler, Arizona, Microchip offers outstanding technical support along with dependable delivery and quality. For more information, visit the Microchip website at www.microchip.com.

    Note: The Microchip name and logo, the Microchip logo and MPLAB are registered trademarks of Microchip Technology Incorporated in the U.S.A. and other countries. All other trademarks mentioned herein are the property of their respective companies.

    The MIL Network

  • MIL-OSI: Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion

    Source: GlobeNewswire (MIL-OSI)

    • Up to $1.25 billion ($250 million upfront) of synthetic royalty funding and up to $750 million in secured debt
    • Innovative partnership enables Revolution Medicines to retain control over pipeline development and global commercialization of daraxonrasib
    • Highlights Royalty Pharma’s unique ability to provide capital at scale to help leading companies achieve their strategic goals
    • Daraxonrasib, in Phase 3 development for pancreatic cancer and non-small cell lung cancer, would be the first targeted therapy to inhibit all major forms of RAS, one of the most common drivers of human cancers

    NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced a $2 billion funding arrangement with Revolution Medicines, consisting of a synthetic royalty of up to $1.25 billion on daraxonrasib and a senior secured loan of up to $750 million. These funds will support Revolution Medicines’ plans for global development and commercialization of daraxonrasib and its pipeline programs for patients with RAS-addicted cancers.

    “We are excited to announce today a groundbreaking partnership that provides Revolution Medicines with up to $2 billion of long-term capital through a customized funding solution that facilitates the expansive development and global commercialization of its leading RAS(ON) inhibitor portfolio,” said Pablo Legorreta, founder and Chief Executive Officer of Royalty Pharma. “This partnership exemplifies a new funding paradigm for highly innovative biotech companies. In contrast to a conventional pharma partnership, this large scale and flexible funding agreement enables Revolution Medicines to retain control of the clinical development of daraxonrasib, as well as the ability to capture significant value creation that would result from the successful clinical development and commercialization of its pipeline.”

    “Today’s announcement represents a major boost to our bold vision on behalf of patients with RAS-addicted cancers,” said Mark A. Goldsmith M.D., Ph.D., Chief Executive Officer and Chairman of Revolution Medicines. “This funding agreement significantly increases the financial resources we can deploy while preserving optionality as we scale our operations to create the industry-leading global targeted medicines franchise for patients with RAS-addicted cancers based on our highly differentiated RAS(ON) inhibitor portfolio.”

    Daraxonrasib, a RAS(ON) multi-selective inhibitor, is a potential practice-changing medicine in Phase 3 development for RAS mutant pancreatic canceri and non-small cell lung cancer (NSCLC). RAS is one of the most commonly mutated genes in human cancer. There are currently no approved targeted therapies that broadly target RAS for these cancers. In the United States, approximately 56,000 patients are diagnosed with RAS-driven pancreatic cancer annually, while approximately 60,000 patients are diagnosed with RAS-driven NSCLC annually. Revolution Medicines expects Phase 3 results for daraxonrasib in pancreatic cancer in 2026 and the Phase 3 NSCLC study is currently enrolling patients.   

    Royalty Terms

    Royalty Pharma will provide up to $1.25 billion in exchange for a synthetic royalty on annual worldwide net sales of daraxonrasib (and zoldonrasib if approved in an overlapping daraxonrasib indication). Details on the terms of the royalty agreement are shown in the table below.

    Royalty terms Tranche 1 Tranche 2 Tranche 3(1) Tranche 4(1) Tranche 5(1) Total
    Amount $250m $250m Up to $250m Up to $250m Up to $250m $1.25 bn
    Timing Immediate Positive data
    (RASolute 302)
    FDA approval in 2L pancreatic cancer Sales milestone achievement Positive Phase 3 data in 1L pancreatic cancer
    Draw Required Required Revolution Medicines option Revolution Medicines option Revolution Medicines option
    Annual sales: Royalty tiers: Royalty tiers: Royalty tiers: Royalty tiers: Royalty tiers: Royalty tiers:
    $0-2 bn
    $2-$4 bn
    $4-$8 bn
    2.55%(2)
    1.50%
    0.60%
    2.00%(2)
    1.00%
    0.40%
    1.50%
    0.80%
    0.40%
    1.00%
    0.75%
    0.50%
    0.75%
    0.50%
    0.50%
    7.80%(2)
    4.55%
    2.40%

    FDA: Food and Drug Administration; 1L: first-line; 2L: second-line
    1 Royalty rates will be adjusted pro-rata depending on draw amount.
    2 The royalty rate on annual sales of $0-2 billion may increase from 2030 to 2041 in the event that sales in the immediate prior year are below an agreed-upon threshold

    Term Loan

    Royalty Pharma will provide a senior secured term loan of up to $750 million at SOFR plus 5.75% (3.5% SOFR floor) which matures six years after the first tranche of $250 million is drawn. The first tranche must be drawn following U.S. Food and Drug Administration approval of daraxonrasib for metastatic pancreatic cancer. The two additional $250 million tranches are available at Revolution Medicines’ option based on the achievement of certain annual net sales milestones for daraxonrasib. Royalty Pharma retains the flexibility to syndicate all or a portion of this loan with other investors.

    Advisors

    Goodwin Procter and Maiwald acted as legal advisors to Royalty Pharma. Latham & Watkins acted as legal advisor and TD Securities acted as financial advisor to Revolution Medicines.

    About Royalty Pharma

    Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly – directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 15 development-stage product candidates.

    Forward-Looking Statements

    The information set forth herein does not purport to be complete or to contain all of the information you may desire. Statements contained herein are made as of the date of this document unless stated otherwise, and neither the delivery of this document at any time, nor any sale of securities, shall under any circumstances create an implication that the information contained herein is correct as of any time after such date or that information will be updated or revised to reflect information that subsequently becomes available or changes occurring after the date hereof. This document contains statements that constitute “forward-looking statements” as that term is defined in the United States Private Securities Litigation Reform Act of 1995, including statements that express the company’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results, in contrast with statements that reflect historical facts. Examples include discussion of Royalty Pharma’s strategies, financing plans, growth opportunities, market growth, and plans for capital deployment. In some cases, you can identify such forward-looking statements by terminology such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “target,” “forecast,” “guidance,” “goal,” “predicts,” “project,” “potential” or “continue,” the negative of these terms or similar expressions. Forward-looking statements are based on management’s current beliefs and assumptions and on information currently available to the company. However, these forward-looking statements are not a guarantee of Royalty Pharma’s performance, and you should not place undue reliance on such statements. Forward-looking statements are subject to many risks, uncertainties and other variable circumstances, and other factors. Such risks and uncertainties may cause the statements to be inaccurate and readers are cautioned not to place undue reliance on such statements. Many of these risks are outside of Royalty Pharma’s control and could cause its actual results to differ materially from those it thought would occur. The forward-looking statements included in this document are made only as of the date hereof. Royalty Pharma does not undertake, and specifically declines, any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect future events or developments, except as required by law. For further information, please reference Royalty Pharma’s reports and documents filed with the U.S. Securities and Exchange Commission (“SEC”) by visiting EDGAR on the SEC’s website at www.sec.gov.

    Royalty Pharma Investor Relations and Communications

    +1 (212) 883-6637
    ir@royaltypharma.com

    _______________________
    i Pancreatic adenocarcinoma (PDAC)

    The MIL Network

  • MIL-OSI: Chris Pogue Joins Calian as President, Defence & Space, Powering Calian’s Next-Generation Defence and Space Capabilities

    Source: GlobeNewswire (MIL-OSI)

    OTTAWA, Ontario, June 24, 2025 (GLOBE NEWSWIRE) — Calian Group Ltd. (TSX: CGY), a mission-critical solutions company focused on defence, space, healthcare and strategic growth critical infrastructure sectors, today announced that Chris Pogue will join the company as President, Defence & Space, effective July 7, 2025. In this newly created role, Pogue will lead a high-performance organization that brings together Calian’s Advanced Technologies and Learning business units—leveraging the synergies of its communications and manufacturing solutions alongside its immersive training and simulation expertise to accelerate mission success for defence and space customers alike.

    “Chris Pogue is one of Canada’s most accomplished leaders in defence and space innovation,” said Kevin Ford, CEO of Calian. “His track record—growing Thales Canada’s support of the Canadian Armed Forces, leading MDA Government’s Radarsat Constellation mission and building global simulation-based services—gives him the vision and operational rigor to power Calian’s next-generation  defence & space capabilities.”

    Pogue brings over 20 years of senior executive experience. He most recently served as President and CEO of Thales Canada, where he expanded naval support services, re-established land-forces capabilities, and guided key AI and digital transformation initiatives. Prior to Thales, he led MDA Government’s Defence Space portfolio and held leadership roles at General Dynamics Mission Systems Canada and CAE Professional Services. Throughout his career, Pogue has championed the development of innovation ecosystems by connecting Canadian small and medium-sized businesses to national defence and space priorities. A retired Royal Canadian Air Force officer with more than 3,500 flight hours on the C-130 Hercules.

    “I’m thrilled to join Calian at such a pivotal time—for the company, and for Canada and its allies—as we face increasingly complex global uncertainty and opportunities,” said Pogue. “Bringing together the subject matter experts and leading-edge solutions from Advanced Technologies and Learning allows us to harness our collective strengths, co-innovate with our space and defence partners, and deliver the reliability and precision mission success demands.”

    This appointment supports the company’s One Calian 2026 strategy—strengthening its ability to deliver mission critical solutions when failure is not an option. It reinforces Calian’s commitment to innovation, customer success and operational excellence as it scales to meet growing global demand.

    About Calian

    www.calian.com

    We keep the world moving forward. Calian® helps people communicate, innovate, learn and lead safe and healthy lives. Every day, our employees live our values of customer commitment, integrity, innovation, respect and teamwork to engineer reliable solutions that solve complex challenges. That’s Confidence. Engineered. A stable and growing 40-year company, we are headquartered in Ottawa with offices and projects spanning North American, European and international markets. Visit calian.com to learn about innovative healthcare, communications, learning and cybersecurity solutions.

    Product or service names mentioned herein may be the trademarks of their respective owners.

    Media inquiries:

    media@calian.com

    613-599-8600

    Investor Relations inquiries:

    ir@calian.com

    DISCLAIMER

    Certain information included in this press release is forward-looking and is subject to important risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Such statements are generally accompanied by words such as “intend”, “anticipate”, “believe”, “estimate”, “expect” or similar statements. Factors which could cause results or events to differ from current expectations include, among other things: the impact of price competition; scarce number of qualified professionals; the impact of rapid technological and market change; loss of business or credit risk with major customers; technical risks on fixed price projects; general industry and market conditions and growth rates; international growth and global economic conditions, and including currency exchange rate fluctuations; and the impact of consolidations in the business services industry. For additional information with respect to certain of these and other factors, please see the Company’s most recent annual report and other reports filed by Calian with the Ontario Securities Commission. Calian disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. No assurance can be given that actual results, performance or achievement expressed in, or implied by, forward-looking statements within this disclosure will occur, or if they do, that any benefits may be derived from them.

    Calian · Head Office · 770 Palladium Drive · Ottawa · Ontario · Canada · K2V 1C8
    Tel: 613.599.8600 · Fax: 613-592-3664 · General info email:
    info@calian.com

    The MIL Network

  • MIL-OSI: Chris Pogue Joins Calian as President, Defence & Space, Powering Calian’s Next-Generation Defence and Space Capabilities

    Source: GlobeNewswire (MIL-OSI)

    OTTAWA, Ontario, June 24, 2025 (GLOBE NEWSWIRE) — Calian Group Ltd. (TSX: CGY), a mission-critical solutions company focused on defence, space, healthcare and strategic growth critical infrastructure sectors, today announced that Chris Pogue will join the company as President, Defence & Space, effective July 7, 2025. In this newly created role, Pogue will lead a high-performance organization that brings together Calian’s Advanced Technologies and Learning business units—leveraging the synergies of its communications and manufacturing solutions alongside its immersive training and simulation expertise to accelerate mission success for defence and space customers alike.

    “Chris Pogue is one of Canada’s most accomplished leaders in defence and space innovation,” said Kevin Ford, CEO of Calian. “His track record—growing Thales Canada’s support of the Canadian Armed Forces, leading MDA Government’s Radarsat Constellation mission and building global simulation-based services—gives him the vision and operational rigor to power Calian’s next-generation  defence & space capabilities.”

    Pogue brings over 20 years of senior executive experience. He most recently served as President and CEO of Thales Canada, where he expanded naval support services, re-established land-forces capabilities, and guided key AI and digital transformation initiatives. Prior to Thales, he led MDA Government’s Defence Space portfolio and held leadership roles at General Dynamics Mission Systems Canada and CAE Professional Services. Throughout his career, Pogue has championed the development of innovation ecosystems by connecting Canadian small and medium-sized businesses to national defence and space priorities. A retired Royal Canadian Air Force officer with more than 3,500 flight hours on the C-130 Hercules.

    “I’m thrilled to join Calian at such a pivotal time—for the company, and for Canada and its allies—as we face increasingly complex global uncertainty and opportunities,” said Pogue. “Bringing together the subject matter experts and leading-edge solutions from Advanced Technologies and Learning allows us to harness our collective strengths, co-innovate with our space and defence partners, and deliver the reliability and precision mission success demands.”

    This appointment supports the company’s One Calian 2026 strategy—strengthening its ability to deliver mission critical solutions when failure is not an option. It reinforces Calian’s commitment to innovation, customer success and operational excellence as it scales to meet growing global demand.

    About Calian

    www.calian.com

    We keep the world moving forward. Calian® helps people communicate, innovate, learn and lead safe and healthy lives. Every day, our employees live our values of customer commitment, integrity, innovation, respect and teamwork to engineer reliable solutions that solve complex challenges. That’s Confidence. Engineered. A stable and growing 40-year company, we are headquartered in Ottawa with offices and projects spanning North American, European and international markets. Visit calian.com to learn about innovative healthcare, communications, learning and cybersecurity solutions.

    Product or service names mentioned herein may be the trademarks of their respective owners.

    Media inquiries:

    media@calian.com

    613-599-8600

    Investor Relations inquiries:

    ir@calian.com

    DISCLAIMER

    Certain information included in this press release is forward-looking and is subject to important risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Such statements are generally accompanied by words such as “intend”, “anticipate”, “believe”, “estimate”, “expect” or similar statements. Factors which could cause results or events to differ from current expectations include, among other things: the impact of price competition; scarce number of qualified professionals; the impact of rapid technological and market change; loss of business or credit risk with major customers; technical risks on fixed price projects; general industry and market conditions and growth rates; international growth and global economic conditions, and including currency exchange rate fluctuations; and the impact of consolidations in the business services industry. For additional information with respect to certain of these and other factors, please see the Company’s most recent annual report and other reports filed by Calian with the Ontario Securities Commission. Calian disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. No assurance can be given that actual results, performance or achievement expressed in, or implied by, forward-looking statements within this disclosure will occur, or if they do, that any benefits may be derived from them.

    Calian · Head Office · 770 Palladium Drive · Ottawa · Ontario · Canada · K2V 1C8
    Tel: 613.599.8600 · Fax: 613-592-3664 · General info email:
    info@calian.com

    The MIL Network

  • MIL-OSI: Array Technologies Announces Proposed Private Offering of $250 Million of New Convertible Senior Notes

    Source: GlobeNewswire (MIL-OSI)

    ALBUQUERQUE, N.M., June 24, 2025 (GLOBE NEWSWIRE) — Array Technologies, Inc. (NASDAQ: ARRY) (the “Company” or “ARRAY”) today announced that, subject to market conditions, it intends to offer $250 million in aggregate principal amount of convertible senior notes due 2031 (the “Notes”) in a private placement (the “Offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A of the Securities Act of 1933, as amended (the “Securities Act”). ARRAY also intends to grant the initial purchasers of the Notes an option to purchase, for settlement within a 13-day period from, and including the date on which the Notes are first issued, up to an additional $37.5 million aggregate principal amount of Notes.

    The Notes will be senior, unsecured obligations of ARRAY, and will accrue interest payable semiannually in arrears. ARRAY will settle conversions by paying cash up to the aggregate principal amount of the Notes to be converted and paying or delivering, as the case may be, cash, shares of ARRAY’s common stock or a combination of cash and shares of ARRAY’s common stock, at ARRAY’s election, in respect of the remainder, if any, of ARRAY’s conversion obligation in excess of the aggregate principal amount of the Notes being converted, based on the then applicable conversion rate.

    The interest rate, the initial conversion rate and certain other terms of the Notes will be determined at the time of pricing of the Offering.

    ARRAY intends to use the net proceeds from the Offering (i) to repay $150 million of the outstanding indebtedness under its term loan facility, (ii) to fund the costs of the capped call transactions described below and (iii) the remainder, if any, for general corporate purposes, which may include additional repayments or repurchases of outstanding indebtedness, including any repurchases of the Existing Convertible Notes (as defined below). If the initial purchasers exercise their option to purchase additional Notes, ARRAY expects to use a portion of the net proceeds from the sale of the additional Notes to enter into additional capped call transactions.    

    In connection with the pricing of the Notes, ARRAY expects to enter into privately negotiated capped call transactions with one or more of the initial purchasers of the Notes or their respective affiliates and/or other financial institutions (the “option counterparties”). The capped call transactions will cover, subject to anti-dilution adjustments, the number of shares of ARRAY’s common stock initially underlying the Notes sold in the Offering. The capped call transactions are expected generally to reduce potential dilution to ARRAY’s common stock upon conversion of any Notes and/or offset any cash payments ARRAY is required to make in excess of the principal amount of converted Notes, as the case may be, with such reduction and/or offset subject to a cap.

    ARRAY has been advised that, in connection with establishing their initial hedges of the capped call transactions, the option counterparties or their respective affiliates expect to purchase shares of ARRAY’s common stock and/or enter into various derivative transactions with respect to ARRAY’s common stock concurrently with or shortly after the pricing of the Notes. This activity could increase (or reduce the size of any decrease in) the market price of ARRAY’s common stock or the Notes at that time. In addition, the option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to ARRAY’s common stock and/or purchasing or selling ARRAY’s common stock or other securities of ARRAY in secondary market transactions following the pricing of the Notes and prior to the maturity of the Notes (and are likely to do so (x) during any observation period related to a conversion of Notes or following any repurchase of Notes in connection with any “fundamental change” (as defined in the indenture for the Notes) and (y) following any other repurchase of Notes if ARRAY elects to unwind a portion of the capped call transactions in connection with such repurchase). This activity could also cause or avoid an increase or decrease in the market price of ARRAY’s common stock or the Notes, which could affect the ability of noteholders to convert the Notes and, to the extent the activity occurs during any observation period related to a conversion of Notes, it could affect the amount and value of the consideration that noteholders will receive upon conversion of the Notes.

    In connection with the pricing of the Notes, ARRAY may enter into one or more separate and individually negotiated transactions with one or more holders of ARRAY’s 1.00% Convertible Senior Notes due 2028 (the “Existing Convertible Notes”) to repurchase for cash a portion of the outstanding Existing Convertible Notes, on terms to be negotiated with each holder, using a portion of the net proceeds from the Offering. No assurance can be given as to how much, if any, of the Existing Convertible Notes will be repurchased or the terms on which they will be repurchased. Holders of any Existing Convertible Notes that are repurchased as described above may enter into or unwind various derivatives with respect to ARRAY’s common stock (including entering into derivatives with one or more of the initial purchasers in the Offering or their respective affiliates) and/or purchase or sell shares of ARRAY’s common stock, which may occur concurrently with or shortly after the pricing of the Notes.

    Neither the Notes nor the shares of ARRAY’s common stock potentially issuable upon conversion of the Notes, if any, have been, or will be, registered under the Securities Act, the securities laws of any other jurisdiction or any state securities laws and, unless so registered, may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws. The Notes will be offered and sold only to persons reasonably believed to be qualified institutional buyers in the United States pursuant to Rule 144A under the Securities Act. This news release is for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, the Notes, nor shall there be any sale of the Notes in any state or jurisdiction in which such offer, solicitation or sale is unlawful. No assurance can be made that the Offering will be consummated on its proposed terms or at all.

    About Array Technologies, Inc.

    ARRAY Technologies, Inc. (NASDAQ: ARRY) is a leading global provider of solar tracking technology to utility-scale and distributed generation customers, who construct, develop, and operate solar PV sites. With solutions engineered to withstand the harshest weather conditions, ARRAY’s high-quality solar trackers, software platforms and field services combine to maximize energy production and deliver value to ARRAY’s customers for the entire lifecycle of a project. Founded and headquartered in the United States, ARRAY is rooted in manufacturing and driven by technology – relying on its domestic manufacturing, diversified global supply chain, and customer-centric approach to design, deliver, commission, train, and support solar energy deployment around the world.

    Media Contact:
    Nicole Stewart
    505-589-8257
    nicole.stewart@arraytechinc.com

    Investor Relations Contact:
    ARRAY Technologies, Inc.

    Investor Relations
    investors@arraytechinc.com

    Forward-Looking Statements

    This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “shall,” “expect,” “anticipate,” “believe,” “seek,” “target,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the anticipated terms of the Notes, the completion, timing and size of the Offering and capped call transactions, the anticipated effects of entering into the capped call transactions, and the intended use of the net proceeds from the Offering, any Existing Convertible Notes repurchases and the anticipated effects thereof. Forward-looking statements involve inherent risks and uncertainties, and important factors (many of which are beyond the Company’s control) that could cause actual results to differ materially from those set forth in the forward looking statements, including risks and uncertainties associated with market conditions, including market interest rates, the trading price and volatility of ARRAY’s common stock, and risks relating to this Offering, the Company’s business and operations and results of financing efforts, including those described in more detail in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 and subsequent reports and other documents on file with the U.S. Securities and Exchange Commission. The forward-looking statements included in this press release speak only as of the date of this press release. Except as required by law, the Company does not undertake, and specifically disclaims, any obligation to update any forward-looking statements to reflect events or circumstances occurring after the date of such statements.

    The MIL Network

  • MIL-OSI Economics: Next-generation monetary and financial system takes shape, based on a tokenised unified ledger: BIS

    Source: Bank for International Settlements

    • Building on the proposal for a unified ledger, the “trilogy” of tokenised central bank reserves, commercial bank money and government bonds is the next logical step to deliver profound change for the financial system.
    • Tokenisation can enhance efficiency and open new possibilities in cross-border payments, securities markets and beyond, while maintaining the key principles of sound money: singleness, elasticity and integrity.
    • Stablecoins as a form of sound money fall short, and without regulation pose a risk to financial stability and monetary sovereignty.

    A tokenised unified ledger incorporating central bank money, commercial bank deposits and government bonds will lay the foundations of a tokenised monetary and financial system based on the time-tested principles of sound money, the Bank for International Settlements said today, as it called on central banks and public authorities to pave the way for this next phase.

    A special chapter of the BIS’s Annual Economic Report 2025 builds on the principles of the unified ledger by laying out a more detailed blueprint for how this concept can combine the “trilogy” of tokenised central bank reserves, tokenised commercial bank money and tokenised government bonds, while maintaining the core elements of a sound monetary system based on trust in central bank money.

    Tokenisation – the digital representation of assets on programmable platforms – integrates messaging, reconciliation and settlement into a single seamless operation, and can transform cross-border payments and securities markets, ushering in a new era for the financial system.

    Tokenisation of deposits and central bank money means that both the primary means of payment as well as the settlement function of central bank money can be integrated seamlessly on the same programmable platform. It has the potential to transform securities markets and its application to correspondent banking is especially promising.

    Hyun Song Shin, Economic Adviser and Head of the Monetary and Economic Department

    While stablecoins may eventually play a subsidiary role in the hinterland of the financial system if adequately regulated, they do not deliver singleness of money (acceptance for payment at par), elasticity (timely discharge of obligations, preventing gridlock) and integrity (safeguarding against financial crime). Therefore, besides acting as a gateway to the crypto ecosystem, their future role is unclear.

    The next-generation monetary and financial system combines the time-tested principles of trust in money underpinned by central banks with the functionality unlocked by tokenisation. This system is poised to deliver substantial improvements to current practices and to enable entirely new economic arrangements. Realising the full potential of the system requires bold actions by central banks, which need to work in partnership with the private sector and other public authorities.

    Agustín Carstens, General Manager

    The BIS and central banks are already driving this vision with Project Agorá, a collaboration led by the BIS with seven central banks and 43 private sector institutions.

    The BIS is not just theorising, it is working with central banks to test and develop tokenisation as the backbone of the future monetary and financial system. The BIS Innovation Hub’s Project Agorá harnesses tokenisation to improve cross-border payments in the banking system and make them seamless, more efficient and cost-effective. Project Pine explores how central banks can implement monetary policy operations in a tokenised world.

    Andréa M Maechler, Deputy General Manager and Acting Head of the BIS Innovation Hub

    Note to editors:

    • The full BIS Annual Economic Report 2025 and the BIS Annual Report 2024/25 will be published on 29 June.

    MIL OSI Economics

  • MIL-OSI NGOs: Oceans Threatened whale species found in areas targeted by The Metals Company for deep sea mining, scientists warn Exeter, UK – 24.06.2025 – A scientific survey of two areas targeted for deep sea mining in the Pacific Ocean by The Metals Company has confirmed the presence of whales… by Alison Kirkman June 24, 2025

    Source: Greenpeace Statement –

    Exeter, UK – 24.06.2025 – A scientific survey of two areas targeted for deep sea mining in the Pacific Ocean by The Metals Company has confirmed the presence of whales and dolphins, including sperm whales which are listed as vulnerable on the IUCN Red List of Threatened Species. 

    The news comes as world governments are about to attend a meeting of the International Seabed Authority (ISA) next month, with 37 governments already voicing their opposition to deep sea mining. The ISA is the intergovernmental body charged with regulating deep sea mining in international waters. It has a mandate to protect the oceans from harmful effects.

    The survey is published today in the scientific journal, Frontiers in Marine Science. It was conducted by researchers from the University of Exeter and Greenpeace Research Laboratories from Greenpeace International’s ship, Arctic Sunrise. It studied two exploration blocks held by The Metals Company in the Pacific’s Clarion-Clipperton Zone (known as NORI-d and TOML-e).

    Dr Kirsten Young of the University of Exeter and lead author of the study said:

    “We already knew that the Clarion-Clipperton Zone is home to at least 20 species of cetaceans, but we’ve now demonstrated their presence in two areas specifically earmarked for deep sea mining by The Metals Company.”

    Following President Trump’s approval of a deep sea mining Executive Order in April, The Metals Company applied to the US government to give TMC unilateral permission to commercially mine the international seabed in the Clarion-Clipperton Zone. According to reports, this application covers the NORI-d area. This bypasses and undermines the International Seabed Authority, the UN regulator for deep sea mining and has been met with strong criticism from governments around the world. Scientists have previously warned of “long lasting, irreversible” impacts of deep sea mining on the region.

    Cetaceans are known to be impacted by noise pollution caused by humans, and could be impacted by the significant noise expected to be created by deep sea mining operations. These operations would also generate sediment plumes, which could impact cetacean populations by disrupting deep ocean food systems.

    Dr Kirsten Young continued:

    “While more research is needed to build a complete picture of the impact of the noise and sediment plumes on cetaceans, it’s clear that deep sea mining operations will negatively impact ocean ecosystems in areas far out to sea where monitoring is particularly challenging.”

    The survey provides a 13-day snapshot of cetacean activity in these two deep sea mining exploration areas. Using hydrophones, the research team confirmed 74 acoustic detections of cetaceans. This included a sperm whale, Risso’s dolphins and common dolphins.

    Louisa Casson of Greenpeace International said:

    “The Metals Company’s plans to mine the seabed in the Pacific are not only a slap in the face for multilateralism and international law, science confirms they would expose some of our most iconic, charismatic and beautiful marine life to noise and other forms of pollution if allowed to go ahead.

    “The confirmed presence of cetaceans, including threatened sperm whales, in areas that The Metals Company is targeting for deep sea mining is yet another clear warning that this dangerous industry must never be allowed to begin commercial operations.

    “If these species are present in TMC licence areas, it’s highly likely they’re across others too, like those sponsored through UK Seabed Resources by the UK Government. We already know from documents obtained via freedom of information requests that minke whales have been observed in UKSR1. 

    “This is no time for the UK and other governments to continue futile discussions about a set of rules to allow deep sea mining to start. The only sensible course of action at next month’s International Seabed Authority meeting would be to prioritise agreeing on a global moratorium.”

    This study in the Pacific is mirrored by another recent piece of Greenpeace research in the Arctic. Researchers found cetaceans, including deep-diving and noise-sensitive sperm whales and northern bottlenose whales, in an area targeted for future mining. If the Norwegian government proceeds with deep sea mining in the area, noise and pollution pose severe consequences. Greenpeace researchers are in the Arctic right now further documenting the presence of cetaceans in the area to expose the risks of deep sea mining and to champion the protection of the Arctic’s vulnerable marine life.

    Calls for a moratorium on deep sea mining grew at the recent UN Ocean Conference, with four new countries joining the group supporting a moratorium, bringing the total to 37. The UN Secretary General also issued a strong call to stop this dangerous industry. Momentum against deep sea mining will now be carried forward to the July ISA meeting.

    Ends

    Download whale and deep sea mining images here

    Download whale videos and images from the ongoing expedition to the proposed mining area in the Norwegian Sea here

    The survey was published today in the Frontiers in Marine Science peer reviewed journal. A full copy of the paper is available on request.

    Contacts:

    Greenpeace International Press Desk: pressdesk.int@greenpeace.org, +31 (0) 20 718 2470 (available 24 hours)

    MIL OSI NGO

  • MIL-OSI Submissions: Middle East turmoil lays the case bare for real portfolio diversification – deVere Group

    Source: deVere Group

    June 24 2025 – The volatile developments across the Middle East—culminating in a dramatic US-brokered ceasefire between Israel and Iran—underscore, yet again, a powerful and urgent truth: diversification isn’t optional. It’s a necessity.

    Markets around the world have been on a knife’s edge for nearly two weeks, reacting sharply to every twist in the conflict.

    Brent crude tumbled nearly 5% after Iran’s missile strike on the Al Udeid air base, interpreted by markets as a restrained signal rather than an escalation.

    With confirmation of the ceasefire, European stocks have surged—Germany’s DAX jumped 2%, the French CAC 40 climbed 1.8%, and futures for the S&P 500 in the US are pointing higher. Yet energy stocks have taken a hit as oil prices slide.

    Nigel Green, CEO of global financial advisory deVere Group, said the “whiplash” in prices across commodities, equities, and safe-haven assets is not just a response to geopolitics—it’s a “flashing red warning light” for investors with narrow allocations.

    “The events of the past two weeks are a textbook case for true portfolio diversification,” he says.

    “One day oil is spiking on nuclear fears, the next it’s plunging on de-escalation. Stocks swing wildly depending on headlines out of Tehran or Tel Aviv. You can’t build or preserve wealth if your investment strategy is overly concentrated in one region, sector, or asset class. That’s not a strategy; that’s a gamble.”

    As the conflict escalated, oil prices spiked on fears of supply disruption. Brent crude surged above $72 before crashing back to near $68 following signs of restraint and the ceasefire announcement. Defence stocks rallied while Middle East-exposed emerging markets sank. Gold flirted with $2,400 as investors scrambled for safety.

    Nigel Green says that for investors, this sequence of events should trigger immediate action.

    “Every global investor must ask themselves today: Am I protected against geopolitical shocks? Do I have meaningful exposure to counter-correlated assets? Am I truly diversified across sectors, geographies, currencies, and asset classes?”

    He adds: “Diversification doesn’t mean owning five different tech stocks or parking all your money in a single bond fund. It means uncorrelated positions across the risk spectrum—think gold, infrastructure, dividend-paying stocks, green energy, and alternatives like real estate and digital assets.”

    Nigel Green also warns that while the ceasefire offers relief, it doesn’t remove risk.

    “This truce is fragile. It’s politically brokered and militarily uneasy. One wrong move and tensions could flare again, dragging markets down with them. That’s the danger of relying too heavily on a single narrative or region in your portfolio.”

    The deVere CEO notes that while markets may breathe a sigh of relief in the short term, the deeper issue is structural instability in a critical region for energy, security, and global trade routes.

    “The Middle East remains a geopolitical powder keg, and history tells us that calm doesn’t last.

    “What does last is a properly diversified portfolio, one that absorbs these shocks without falling apart.”

    With global equities rallying and oil prices sliding, some investors may be tempted to lean back into familiar strategies. Nigel Green says this would be a critical mistake.

    “When markets are jittery, many investors double down on what they know—often increasing risk without realising it. What’s needed now is a measured, deliberate shift into broader exposure.”

    He concludes: “You diversify when the skies are clear, so that you’re protected when the storm breaks.

    “But after what we’ve just seen in the Middle East, the need for real diversification isn’t hypothetical, it’s immediate.”

    deVere Group is one of the world’s largest independent advisors of specialist global financial solutions to international, local mass affluent, and high-net-worth clients.  It has a network of offices around the world, more than 80,000 clients, and $14bn under advisement.

    MIL OSI – Submitted News

  • MIL-OSI Africa: Qatar Affirms Continued Support for Afghan People in Facing Multiple Challenges, Assisting Them to Achieving Peace and Stability

    Source: Government of Qatar

    New York, June 24, 2025

    The State of Qatar reaffirmed its continued support for the Afghan people in facing multiple challenges and its commitment to assisting them on the path toward achieving peace and stability. Qatar also expressed its keenness to continue working with regional and international partners to establish the foundations of peace in Afghanistan and strengthen the elements of development.

    This came in the State of Qatar’s statement delivered by HE Permanent Representative of the State of Qatar to the United Nations Sheikha Alya Ahmed bin Saif Al-Thani during the United Nations Security Council’s Quarterly Briefing on Situation in Afghanistan, held at the UN headquarters in New York.

    Her Excellency emphasized that the humanitarian, economic, and political situations in Afghanistan require enhanced joint efforts to support and assist the Afghan people. She noted that the security and stability of Afghanistan positively impact regional and international security and peace.

    HE further pointed out that the State of Qatar took the initiative to establish the Doha peace track for Afghanistan in 2013 in cooperation with international partners, and hosted a series of dialogues as part of a comprehensive political process involving all segments of Afghan society. She added that these efforts culminated in the signing of the Agreement for Bringing Peace to Afghanistan between US and Taliban in Doha on Feb. 29, 2020, which the UN Security Council described in its Resolution 2513 as a significant step toward ending the war and opening the door to intra-Afghan negotiations.

    Her Excellency said that since then, the State of Qatar has continued its contribution by coordinating international efforts and facilitating dialogue between the United Nations, concerned countries, and the Afghan caretaker government, adding that the State of Qatar takes pride in hosting the UN-led Doha Process on Afghanistan, starting with the meetings of the UN Special Envoys on Afghanistan convened by the UN Secretary-General in Doha in May 2023, February 2024, and July 2024, with the aim of reaching a comprehensive approach to facilitating initial international engagement in a more coherent and coordinated manner for the sake of peace and stability in Afghanistan.

    Her Excellency expressed the State of Qatar’s aspiration to host the third meeting of the Working Group on Counter-Narcotics and the second meeting of the Working Group on Supporting Afghanistan’s Private Sector, both emerging from the UN-led Doha Process on Afghanistan, which will be held in Doha from June 30 to July 1, with the participation of representatives from the Afghan caretaker government, countries involved in the Doha Process, and technical experts.

    HE stressed that the State of Qatar continues its efforts through the Qatar Fund for Development, in cooperation with United Nations entities, to provide humanitarian support to the Afghan people, including food aid, supporting basic healthcare programs, improving Afghan children’s access to education, providing scholarships, supporting programs to economically empower Afghan women and enhance their resilience to crises, and backing programs that empower Afghan youth, HE added.

    MIL OSI Africa

  • MIL-OSI Africa: Ministry of Foreign Affairs Summons Iranian Ambassador, Reiterates Qatar’s Strong Condemnation of Violation of Its Sovereignty and Airspace

    Source: Government of Qatar

    Doha, June 24, 2025

    The Ministry of Foreign Affairs summoned on Tuesday HE Ambassador of the Islamic Republic of Iran to the State of Qatar Ali Salehabadi, and reiterated the State of Qatar’s strong condemnation of the attack on Al-Udeid Air Base by the Iranian Revolutionary Guard, considering it a blatant violation of its sovereignty and airspace, as well as of the international law and the United Nations Charter. It also affirmed that the State of Qatar reserves the right to respond to this flagrant violation in accordance with international law.

    HE Minister of State for Foreign Affairs Sultan bin Saad Al Muraikhi affirmed to the Iranian Ambassador that this violation is completely inconsistent with the principle of good neighborliness and the close relations that exist between the State of Qatar and the Islamic Republic of Iran—especially considering that Qatar has always advocated for dialogue with Iran and has made considerable diplomatic efforts in this regard.

    HE Minister of State for Foreign Affairs also emphasised the urgent need to immediately return to dialogue and diplomatic channels to resolve disputes and outstanding issues, avoid escalation, and halt military operations in an effort to promote regional and international stability.

    MIL OSI Africa

  • MIL-OSI Africa: Minister of State for Foreign Affairs Receives Phone Call from Spanish Secretary of State for Foreign, Global Affairs

    Source: Government of Qatar

    Doha, June 24, 2025

    HE Minister of State for Foreign Affairs Sultan bin Saad Al Muraikhi received a phone call on Tuesday from HE Secretary of State for Foreign and Global Affairs of the Kingdom of Spain Diego Martinez Belio.

    During the phone call, they discussed cooperation relations between the two countries and ways to support and enhance them, in addition to other topics of mutual interest.

    HE Spanish Secretary of State for Foreign and Global Affairs expressed his country’s solidarity with the State of Qatar after the Iranian missile attack on Qatar’s Al-Udeid Air Base.

    MIL OSI Africa

  • Wi-Fi sector projected to hit $22 billion by 2035, says Jyotiraditya Scindia

    Source: Government of India

    Source: Government of India (4)

    Union Minister for Communications and Development of the Northeastern Region, Jyotiraditya Scindia, on Tuesday said India is fast becoming a global digital leader, with Wi-Fi expected to play a key role in bridging the digital divide. Speaking at a World Wi-Fi Day event organised by the Broadband India Forum in Delhi, Scindia called Wi-Fi an “invisible force capable of powering visible change.”

    “Wi-Fi is not just about internet access; it’s about widespread inclusion,” the Minister said, adding, “Every hotspot must become a hope spot.”

    Scindia noted that the Wi-Fi segment in India is projected to grow into a $22 billion industry by 2035, underscoring its transformative role in the country’s digital journey. He emphasised that connectivity today is no longer a luxury but a fundamental necessity — as crucial as access to capital and infrastructure was in the past.

    Highlighting the government’s rural-first approach, Scindia said that India’s 5G use cases are being piloted in 13 villages across states like Andhra Pradesh and Madhya Pradesh, rather than beginning in urban centres. “We must light up every rural home, empower every aspiring mind, and fortify public services with the power of Wi-Fi,” he said.

    The Minister also spoke of India’s strides in telecom technology, noting that the country has joined a select group of five nations that have developed their own 4G technology stack. This, he said, was achieved through collaboration between public and private sector players like CDOT, Tejas Networks, and Tata Consultancy Services (TCS).

    “India today has become the leader of the digital world,” Scindia said, referring to the indigenous 4G stack developed domestically.

    Citing data usage patterns, Scindia said India now accounts for 46 per cent of all digital transactions globally, outpacing the US, Europe, and China. He attributed this growth to India’s low-cost data model, which offers data at ₹9 per GB — far lower than the global average of $2.49.

    He also lauded the PM-WANI (Wi-Fi Access Network Interface) initiative, calling it a “game-changer” in expanding internet access in rural and underserved regions. Scindia stressed the importance of deregulating spectrum to enhance access further, noting that the recent de-licensing of the 6 GHz band will enable faster, more affordable connectivity. Guidelines for this policy, he said, would be announced before Independence Day 2025.

    Calling on the industry to innovate in the hardware space, Scindia cautioned that device affordability must not become the next barrier to connectivity. “Connectivity is not a commodity; it is an act of nation-building,” he said.

    The Minister urged a collective reflection on the power of wireless connectivity. “It gives us the freedom to connect, to create, and to rise,” he said.

    ANI

  • MIL-OSI United Kingdom: The Judicial Committee of the Privy Council overturns Jersey’s first declaration of incompatibility with human rights law24 June 2025 Jersey’s Attorney General, Mark Temple KC, and the Jersey Competent Authority, the Minister for Treasury and Resources, have succeeded in a landmark appeal before the Judicial Committee of the Privy… Read more

    Source: Channel Islands – Jersey

    24 June 2025

    Jersey’s Attorney General, Mark Temple KC, and the Jersey Competent Authority, the Minister for Treasury and Resources, have succeeded in a landmark appeal before the Judicial Committee of the Privy Council. 

    In a ruling handed down this morning, Jersey’s highest appellate court overturned the declaration made by the Court of Appeal last year under the Human Rights (Jersey) Law 2000 that the International Co-operation (Protection from Liability) (Jersey) Law 2018 is incompatible with human rights. This was the first declaration of incompatibility made by a Jersey court. 

    That Law, introduced in 2018, includes provisions that place limits on the costs and damages that can be awarded against public authorities in Jersey where public authorities have made decisions in good faith to fulfil a request from the authority of another country. The Court of Appeal had found that these provisions infringed Article 6(1) of the European Convention on Human Rights (ECHR) – ie the right to a fair trial in a civil case. However, the Attorney General and Jersey’s Competent Authority in tax information exchange cases have now succeeded, on appeal, in reversing that decision and other findings of the Court of Appeal. 

    Commenting on today’s judgment, Jersey’s Attorney General, Mark Temple KC said: “I am pleased that the Judicial Committee has allowed this appeal and overturned the declaration of incompatibility. I explained at the hearing of the appeal that the matter was of great importance for Jersey and that the Court of Appeal’s decision was the first time that a declaration of incompatibility had been made by a court in Jersey. I am therefore also grateful to the Judicial Committee for providing authoritative guidance concerning applications for declarations of incompatibility under the Human Rights (Jersey) Law 2000 and whether legislation pursues a legitimate aim.” 

    Deputy Elaine Millar, Minister for Treasury and Resources, commented: “I also welcome this judgment. It is vital that Jersey has a robust domestic legal framework which enables the Island to comply with its international obligations – in this case Jersey’s obligations under the OECD Mutual Assistance Convention, which are important for our financial services industry – in a timely and effective way. The States Assembly enacted the 2018 Law to ensure that public authorities in Jersey should not be constrained by the threat of large, unexpected costs liabilities when they are acting to provide assistance in good faith to other countries.” 

    The Court of Appeal had made the declaration in proceedings brought by Imperium Trustees (Jersey) Limited to challenge a notice issued in 2022 by the office of the Comptroller of Revenue on behalf of the Minister as the Jersey Competent Authority to produce tax information, for exchange with the authorities of Belgium, concerning a Jersey law trust administered by Imperium. 

    The Judicial Committee has found, contrary to the Court of Appeal, that the essential nature of those underlying proceedings is a “tax matter” as the core issue to be resolved is the lawfulness of a notice to produce tax information, not one of the peripheral issues relating to confidentiality that were raised by Imperium. 

    In the case law of the European Court of Human Rights, tax matters form part of what is known as “the hard core of public authority prerogatives”, being areas of law involving the state’s exercise of its public authority, which fall outside the scope of what are considered “civil rights and obligations” within Article 6(1) ECHR. 

    As a result, Article 6(1) ECHR was found not to be engaged in the Imperium case, and this was sufficient for the Judicial Committee to uphold the whole appeal. The Judicial Committee chose, however, to make a number of further points in relation to the Court of Appeal’s wider decision and the procedure it had followed in the context of rights under the ECHR. 

    In particular, the Judicial Committee was critical of the declaration having been made in an abstract manner without any actual evidence of the infringement of the rights of the persons before the court, namely Imperium. The Board said it was not open for the Court to do so by reference to litigants and matters that were not before the Court. 

    The justices also took issue with how the majority of the Court of Appeal had approached the question of whether the 2018 Law pursued a legitimate aim. They approved the statement by Jersey Justice of Appeal James Wolffe KC, who had dissented on this point in the Court of Appeal, that the correct approach is to have regard to the Law’s underlying social purpose, to focus not on what the measure does but the reason why it was enacted. Therefore, it was permissible for the Court to look beyond the provisions of the Law itself; to examine materials such as the Projet de Loi and the speeches made by the Ministers and Scrutiny Panel members in the States Assembly as recorded in Hansard.

    The judgment of the Judicial Committee is available here​.​​

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Manchester City Council takes pioneering step to tackle end of life poverty

    Source: City of Manchester

    Manchester Council and the UK’s leading end of life charity Marie Curie are working together to ensure people in the city who are living with a terminal illness become exempt from paying Council Tax.

    Carried out as part of a larger plan to support the most vulnerable residents in Manchester, the Council has looked at as many ways as possible to help those who know have been struggling over recent years.

    Marie Curie’s recent ‘Dying in Poverty’ report found that in Manchester around 42% of working age and 30% of pension age residents die in poverty. 

    Addressing this profoundly important issue is at the heart of the Council’s strategy, with a number of key changes being made in recent years directed at tackling the root causes of poverty, and ensuring that people do not slip back into it.

    This new proposal sets out a plan for the council to change its Discretionary Council Tax Policy (DCTP) to explicitly include a commitment to support people who have been diagnosed with a terminal illness.

    This form is completed by a clinician which confirms a person has a progressive disease, and consequently their patient is expected to pass away within a 12-month period.

    Using DCTP the Council will make up the difference of any shortfall in CTS so that in any situation where a member of the household qualifies – whether an adult, child or non-dependant – the household will have nothing to pay. The support will then apply to the household’s council tax bill until the date of the persons death.

    The Council will also be working to ensure that a “tell us once” protocol is in place so that, in the event of a claimant’s passing, no undue burden will fall upon their family. Steps will also be in place to retain the discount for the remainder of the financial year in the event of a person’s passing, to provide additional support for their family.

    It is estimated that this scheme would support around 175 residents in Manchester, the majority of which would be of working age.

    In addition to this change in policy, a great deal of work has already been carried out to alleviate the worst of the cost-of-living crisis for Mancunians.

    To date the Council has:

    • Provided free school meals to 46,000 children and young people during the holidays over the past year
    • Directed more than £1m of supplies to community food banks and groups since 2022, spending an additional £155,000 on food-related support for residents
    • Connected with close to 14,000 people via our Cost-of-Living Advice Line since October 2022
    • Distributed more than 2,000 phones, laptops or computers to people who may be digitally excluded, as well as providing more than 7,000 SIM cards since 2020
    • Made £2.6m in grant payments to nearly 2,122 residents to help them stay in their homes
    • Issued £1m in grant funding to 70 voluntary and community organisations who last year were able to help around 54,000 residents
    • The Holiday Activity Fund, which provides free activities as well as a free meal to children during the holidays has seen more than 24,000 children attend during half terms and summer holidays

    Councillor Bev Craig, Leader of Manchester City Council said: “The moment when you or your family member gets the devastating news of terminal illness is heartbreaking. The last thing you need to worry about money and bills, but we know for too many people it takes up too much time and stress.

    “Too many people are living in poverty in our city and the council is committed to doing all it can to alleviate it in the short term, and build ways out of poverty in the long term. That’s why we are exempting people with a terminal illness from Council Tax alongside a wider package of support with the cost of living, doing everything in our power to ensure families have one less thing to worry about during such a difficult time.

    “We want to thank Marie Curie for their vital work, and as a Council want to do all we can to ease the burden at the end of someone’s life.”

    Jamie Thunder, Senior Policy Manager for Financial Security at Marie Curie, said: “The end of life should be a time to focus on what really matters – but for too many people, it’s dominated by financial difficulty as their income drops and costs rise.

    “We’re therefore delighted that Manchester City Council are taking this pioneering step, which will make a real difference to people with a terminal illness at the time they need it most. We hope other councils in the North West and across the country will follow suit, and help to ensure that no-one dies in poverty.”

    MIL OSI United Kingdom

  • MIL-OSI Russia: Registration for the night bike festival has opened in the capital

    Translation. Region: Russian Federal

    Source: Moscow Government – Government of Moscow –

    The night bike festival will take place in the capital on July 5. Participation in one of the brightest summer events for fans of cycling and active recreation is free, but advance registration on the official website of the event is required.

    “Residents and guests of the capital have come to love our cycling festivals. More and more participants join them each time. This year, Sergei Sobyanin has ordered two night cycling festivals to be held. Anyone interested can already register for the first night cycling race, which will take place on July 5,” said Deputy Mayor of Moscow for Transport and Industry

    Maxim Liksutov.

    Festival program

    The starting town will open at 20:00. The start of the race is divided into two time intervals: at 21:00 and at 22:00. Participants choose the time when registering. The 27-kilometer route will start from Luzhnetskaya Embankment and end near Sokolniki Park. The entertainment program will last four hours and end at midnight.

    The organizers remind: to ensure that all participants are comfortable, it is important to arrive at the start within the selected time slot. For safety reasons, they are advised to use equipment: a helmet, elbow and knee protection, and bicycle lights. Details and registration are available atwebsite events.

    Get the latest news quicklyofficial telegram channel the city of Moscow.

    Please note: This information is raw content directly from the source of the information. It is exactly what the source states and does not reflect the position of MIL-OSI or its clients.

    Please Note; This Information is Raw Content Directly from the Information Source. It is access to What the Source Is Stating and Does Not Reflect

    https: //vv.mos.ru/nevs/ite/155750073/

    MIL OSI Russia News

  • MIL-OSI: BloFin futures performance rivals top exchanges across BTC, ETH, and leading altcoins

    Source: GlobeNewswire (MIL-OSI)

    ROAD TOWN, Virgin Islands, June 24, 2025 (GLOBE NEWSWIRE) — BloFin strengthens its position as a global leader in futures trading liquidity and slippage control, outperforming mid-tier competitors and matching the performance of top-tier exchanges.

    BloFin Exchange has achieved a significant milestone in future market performance, establishing itself as a top-tier competitor in both liquidity and trade execution quality. According to the latest official data collected via API monitoring from June 16 to June 19, 2025, BloFin’s futures market depth and slippage performance position the exchange alongside long-established industry leaders such as Binance, OKX, and Bybit, further solidifying its reputation among global futures market participants.

    Tier-1 futures liquidity achieved, with a top-two global ranking across depth metrics

    In cumulative futures depth at both the 0.1% and 0.05% price deviation levels, BloFin ranked firmly among the top three global exchanges. Its liquidity performance not only outpaced all mid-tier platforms but also closely matched or exceeded several tier-1 competitors.

    • At the 0.1% depth level, BloFin secured the second position in overall futures liquidity with a total cumulative depth of 92.6 million, surpassing OKX and coming in just behind Binance.
    • At the 0.05% depth level, BloFin maintained a strong second-place ranking with a cumulative depth of 46.1 million, outperforming both OKX and Binance under tighter market conditions.

    These results demonstrate BloFin’s consistent capacity to support high-volume, low-slippage trading activity for institutional participants and large-volume retail users.

    Whale-grade slippage control delivers execution quality on par with leading exchanges

    In addition to liquidity depth, BloFin exhibited robust trade execution metrics under stress-tested conditions. The exchange delivered highly competitive slippage rates for both BTC and ETH futures, alongside a wide range of over 15 actively traded altcoins, including SOL, XRP, DOGE, PEPE, ADA, and TRUMP.

    BloFin’s slippage performance for major assets under two levels of simulated stress remained in line with top-tier platforms, confirming the exchange’s ability to maintain price stability and execution efficiency in volatile or high-demand trading environments. Notably, BloFin also offered lower slippages for trending, volatile altcoins — an area where many mid-tier competitors face significant execution gaps.

    A new global contender reshaping the futures trading landscape

    BloFin’s performance in this report affirms its standing as a rising leader in the global futures market. By delivering futures market depth and slippage control on par with tier-1 exchanges, BloFin strengthens its appeal to whales, institutional traders, and high-frequency participants seeking deep liquidity and reliable trade execution across both dominant and emerging digital assets.

    As the exchange continues its expansion into key global markets and strategic event sponsorships, this achievement further enhances BloFin’s credibility as a serious futures market contender.

    About BloFin

    BloFin is a top-tier cryptocurrency exchange that specializes in futures trading. The platform offers 480+ USDT-M perpetual pairs, Coin-Margined Perpetual Contracts, spot trading, copy trading, API access, unified account management, and advanced sub-account solutions. Committed to security and compliance, BloFin integrates Fireblocks and Chainalysis to ensure robust asset protection. By partnering with top affiliates, BloFin delivers scalable trading solutions, efficient fund management, and enhanced flexibility for professional traders. As the constant sponsor of TOKEN2049, BloFin continues to expand its global presence, reinforcing its position as the place “WHERE WHALES ARE MADE.” For more information, visit BloFin’s official website at https://www.blofin.com.

    Contact:

    Annio W.
    annio@blofin.io

    Disclaimer: This is a paid post and is provided by Blofin. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. We do not guarantee any claims, statements, or promises made in this article. This content is for informational purposes only and should not be considered financial, investment, or trading advice. Investing in crypto and mining-related opportunities involves significant risks, including the potential loss of capital. It is possible to lose all your capital. These products may not be suitable for everyone, and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. However, due to the inherently speculative nature of the blockchain sector—including cryptocurrency, NFTs, and mining—complete accuracy cannot always be guaranteed. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility. Globenewswire does not endorse any content on this page.

    Legal Disclaimer: This media platform provides the content of this article on an “as-is” basis, without any warranties or representations of any kind, express or implied. We assume no responsibility for any inaccuracies, errors, or omissions. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above.

    Photos accompanying this announcement are available at

    https://www.globenewswire.com/NewsRoom/AttachmentNg/ed503f50-4ab2-41f1-95cc-7e54a90942aa

    https://www.globenewswire.com/NewsRoom/AttachmentNg/f1d05780-6070-4dad-b940-987dc2f69334

    https://www.globenewswire.com/NewsRoom/AttachmentNg/6e7cd7e1-174f-4e74-be9c-8b38f4acad05

    The MIL Network

  • MIL-OSI: BloFin futures performance rivals top exchanges across BTC, ETH, and leading altcoins

    Source: GlobeNewswire (MIL-OSI)

    ROAD TOWN, Virgin Islands, June 24, 2025 (GLOBE NEWSWIRE) — BloFin strengthens its position as a global leader in futures trading liquidity and slippage control, outperforming mid-tier competitors and matching the performance of top-tier exchanges.

    BloFin Exchange has achieved a significant milestone in future market performance, establishing itself as a top-tier competitor in both liquidity and trade execution quality. According to the latest official data collected via API monitoring from June 16 to June 19, 2025, BloFin’s futures market depth and slippage performance position the exchange alongside long-established industry leaders such as Binance, OKX, and Bybit, further solidifying its reputation among global futures market participants.

    Tier-1 futures liquidity achieved, with a top-two global ranking across depth metrics

    In cumulative futures depth at both the 0.1% and 0.05% price deviation levels, BloFin ranked firmly among the top three global exchanges. Its liquidity performance not only outpaced all mid-tier platforms but also closely matched or exceeded several tier-1 competitors.

    • At the 0.1% depth level, BloFin secured the second position in overall futures liquidity with a total cumulative depth of 92.6 million, surpassing OKX and coming in just behind Binance.
    • At the 0.05% depth level, BloFin maintained a strong second-place ranking with a cumulative depth of 46.1 million, outperforming both OKX and Binance under tighter market conditions.

    These results demonstrate BloFin’s consistent capacity to support high-volume, low-slippage trading activity for institutional participants and large-volume retail users.

    Whale-grade slippage control delivers execution quality on par with leading exchanges

    In addition to liquidity depth, BloFin exhibited robust trade execution metrics under stress-tested conditions. The exchange delivered highly competitive slippage rates for both BTC and ETH futures, alongside a wide range of over 15 actively traded altcoins, including SOL, XRP, DOGE, PEPE, ADA, and TRUMP.

    BloFin’s slippage performance for major assets under two levels of simulated stress remained in line with top-tier platforms, confirming the exchange’s ability to maintain price stability and execution efficiency in volatile or high-demand trading environments. Notably, BloFin also offered lower slippages for trending, volatile altcoins — an area where many mid-tier competitors face significant execution gaps.

    A new global contender reshaping the futures trading landscape

    BloFin’s performance in this report affirms its standing as a rising leader in the global futures market. By delivering futures market depth and slippage control on par with tier-1 exchanges, BloFin strengthens its appeal to whales, institutional traders, and high-frequency participants seeking deep liquidity and reliable trade execution across both dominant and emerging digital assets.

    As the exchange continues its expansion into key global markets and strategic event sponsorships, this achievement further enhances BloFin’s credibility as a serious futures market contender.

    About BloFin

    BloFin is a top-tier cryptocurrency exchange that specializes in futures trading. The platform offers 480+ USDT-M perpetual pairs, Coin-Margined Perpetual Contracts, spot trading, copy trading, API access, unified account management, and advanced sub-account solutions. Committed to security and compliance, BloFin integrates Fireblocks and Chainalysis to ensure robust asset protection. By partnering with top affiliates, BloFin delivers scalable trading solutions, efficient fund management, and enhanced flexibility for professional traders. As the constant sponsor of TOKEN2049, BloFin continues to expand its global presence, reinforcing its position as the place “WHERE WHALES ARE MADE.” For more information, visit BloFin’s official website at https://www.blofin.com.

    Contact:

    Annio W.
    annio@blofin.io

    Disclaimer: This is a paid post and is provided by Blofin. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. We do not guarantee any claims, statements, or promises made in this article. This content is for informational purposes only and should not be considered financial, investment, or trading advice. Investing in crypto and mining-related opportunities involves significant risks, including the potential loss of capital. It is possible to lose all your capital. These products may not be suitable for everyone, and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. However, due to the inherently speculative nature of the blockchain sector—including cryptocurrency, NFTs, and mining—complete accuracy cannot always be guaranteed. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility. Globenewswire does not endorse any content on this page.

    Legal Disclaimer: This media platform provides the content of this article on an “as-is” basis, without any warranties or representations of any kind, express or implied. We assume no responsibility for any inaccuracies, errors, or omissions. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above.

    Photos accompanying this announcement are available at

    https://www.globenewswire.com/NewsRoom/AttachmentNg/ed503f50-4ab2-41f1-95cc-7e54a90942aa

    https://www.globenewswire.com/NewsRoom/AttachmentNg/f1d05780-6070-4dad-b940-987dc2f69334

    https://www.globenewswire.com/NewsRoom/AttachmentNg/6e7cd7e1-174f-4e74-be9c-8b38f4acad05

    The MIL Network

  • MIL-OSI: KIF18A Inhibitor Clinical Trials FDA Approved KIF18A Targeting Therapies Market Report

    Source: GlobeNewswire (MIL-OSI)

    Delhi, June 24, 2025 (GLOBE NEWSWIRE) — Global KIF18A Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025 Report Highlights & Findings:

    • First KIF18A Targeting Therapy Commercial Availability Expected By 2030
    • Highest Phase Of Development: Phase-I/II
    • KIF18A Targeting Therapies In Clinical Trials:  > 10 Therapies
    • KIF18A Targeting Therapies Clinical Trials Insight By Company, Country, Indication & Phase
    • KIF18A Targeting Therapies Market Development Trends Insight
    • KIF18A Therapies Technology Platforms Insight

    Download Report: https://www.kuickresearch.com/report-kif18a-targeting-inhibitor-kif18a-inhibitor-clinical-trials-kif18a-targeting-therapy

    The global oncology landscape is witnessing rapid progress in precision medicine, and one of the most lead nominees in emerging targets is Kinesin Family Member 18A (KIF18A). It is a mitotic motor protein that is essential for chromosome alignment during mitosis, which facilitates proper segregation of chromosomes. Its perturbation leads to genomic instability, which is a distinguishing feature of cancer. Extrapolations of KIF18A have also been seen in various cancers such as ovarian and breast cancer, with an association with prognosis, drug resistance, and the potential to metastasize. As a crucial protein involved in mitosis and overexpression in cancer, KIF18A is now a promising therapeutic target.

    Targeting KIF18A interferes with mitotic mechanisms in chromosomally unstable (CIN-positive) cancer cells, causing selective death of cancer cells. In contrast to conventional chemotherapies, which indiscriminately impact all proliferating cells, KIF18A inhibitors provide a more selective and less toxic option by taking advantage of cancer cells’ vulnerability to proper mitosis. The major approach is small molecule inhibitors that disrupt KIF18A’s motor activity, hindering it from modulating microtubule dynamics at the kinetochore. It leads to mitotic arrest and failure of chromosome alignment, ultimately triggering apoptosis in cancer cells.

    Clinical development is progressing well. Volastra Therapeutics, a forerunner in this arena, is developing two KIF18A-targeting molecules: Sovilnesib (AMG650), acquired from Amgen and underway in Phase I trials for platinum-resistant high-grade serous ovarian cancer, and VLS-1488, an in-house oral inhibitor in Phase I/II. Both molecules displayed favorable safety profiles and early anti-tumor effects, with particular efficacy in high-chromosomal-instability tumors. Volastra’s pipeline demonstrates the therapeutic potential of inhibiting KIF18A to treat difficult-to-treat cancers.

    Accent Therapeutics is also advancing with ATX-295, an oral KIF18A inhibitor in initial clinical testing for solid tumors such as triple-negative breast and high-grade serous ovarian cancers. Their biomarker strategy makes use of genomic instability markers such as whole-genome doubling to better optimize patient selection and optimize therapy outcomes.

    AI based drug discovery is providing additional impetus to this area. Insilico Medicine has utilized proprietary platforms such as Chemistry42 and PandaOmics to discover ISM9682, a new macrocyclic KIF18A inhibitor with high preclinical efficacy. The AI platforms facilitate rapid optimization of candidates with increased specificity and pharmacological profiles, highlighting the growing use of sophisticated computational approaches in drug discovery.

    Aside from clinical advancement, the market opportunity for KIF18A inhibitors is also robust. As precision oncology gains more attention, the therapies are well poised to capture the opportunity of targeted therapies, particularly in diseases that are refractory to current treatments. Various companies, including Nvidia-funded Iambic Therapeutics, Aurigene Oncology, Simcere Zaiming Pharmaceutical, and Amgen, are developing promising product candidates in preclinical phases.

    Overall, the KIF18A-targeted therapy market is changing very quickly, powered by strong scientific justification, initial clinical success, and novel development approaches. As additional preclinical and clinical information becomes available, the market has significant potential for strong growth, powered by partnerships, application of artificial intelligence and machine learning tactics, and the overall dedication to creating targeted and individualized cancer therapeutics.

    The MIL Network

  • MIL-OSI: Walking Comfort Accelerates Ecommerce Growth with Descartes Sellercloud™

    Source: GlobeNewswire (MIL-OSI)

    ATLANTA, June 24, 2025 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Utah-based Walking Comfort, a leading retailer in the local and online footwear market, is using Descartes Sellercloud™ to help drive ecommerce growth by centralizing and synchronizing the management of product listings, inventory, orders and fulfillment across multiple online sales channels.

    “As the business grew and we expanded to a larger warehouse and more online marketplaces, we realized we needed a more sophisticated inventory and order management system to boost time-savings and operating efficiencies,” said Brad Hendricksen, Accounting and Operations Manager at Walking Comfort. “With Descartes Sellercloud, we have a powerful platform that has facilitated ecommerce growth, saved us hundreds of hours per week by automatically consolidating data across all sales channels, eliminated picking errors so staff no longer pick the wrong size or variation, and cut shipping costs by more than 55%—even enabling us to dropship directly from retail locations if it’s the most convenient and cost-effective option for a customer.”

    Descartes Sellercloud is a cloud-based ecommerce platform that helps small and mid-market retailers, distributors, wholesalers, and manufacturers with omnichannel ecommerce operations centralize the management of their catalog, inventory, orders, purchasing, fulfillment and shipping. With 350+ integrations, including to marketplaces, shopping carts, shipping partners, third party logistics providers, payment gateways and vendors, the solution provides a comprehensive ecommerce ecosystem that companies can easily leverage to expand operations as they grow.

    “We’re pleased our solution is supporting Walking Comfort as they’ve grown their business,” said Mikel Richardson, General Manager, Ecommerce at Descartes. “Using the platform, sellers can reduce operational complexity by simultaneously updating inventory and orders in real-time, avoid underselling and overselling inventory, stay compliant with marketplaces requirements, save shipping costs by automating fulfillment, and grow their business by adding more sales channels and products without losing control of inventory or order visibility.”

    Learn more about Descartes Sellercloud and Descartes’ Ecommerce Shipping and Fulfillment solutions.

    About Walking Comfort

    Walking Comfort sells various footwear products, including running shoes, slippers, sandals, recovery footwear, and accessories like insoles. Founded in 2008, they are based in Centerville, Utah, and have 35 employees and two brick-and-mortar locations. For more information, visit www.walkingcomfort.com.

    About Descartes

    Descartes (Nasdaq:DSGX) (TSX:DSG) is the global leader in providing on-demand, software-as-a-service solutions focused on improving the productivity, security and sustainability of logistics-intensive businesses. Customers use our modular, software-as-a-service solutions to route, track and help improve the safety, performance and compliance of delivery resources; plan, allocate and execute shipments; rate, audit and pay transportation invoices; access global trade data; file customs and security documents for imports and exports; and complete numerous other logistics processes by participating in the world’s largest, collaborative multimodal logistics community. Our headquarters are in Waterloo, Ontario, Canada and we have offices and partners around the world. Learn more at www.descartes.com, and connect with us on LinkedIn and Twitter.

    Global Media Contact
    Cara Strohack
    Tel: 226-750-8050
    cstrohack@descartes.com

    Cautionary Statement Regarding Forward-Looking Statements

    This release contains forward-looking information within the meaning of applicable securities laws (“forward-looking statements”) that relate to Descartes’ ecommerce solution offerings and potential benefits derived therefrom; and other matters. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements to differ materially from the anticipated results, performance or achievements or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the factors and assumptions discussed in the section entitled, “Certain Factors That May Affect Future Results” in documents filed with the Securities and Exchange Commission, the Ontario Securities Commission and other securities commissions across Canada including Descartes’ most recently filed management’s discussion and analysis. If any such risks actually occur, they could materially adversely affect our business, financial condition or results of operations. In that case, the trading price of our common shares could decline, perhaps materially. Readers are cautioned not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Forward-looking statements are provided for the purposes of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes. We do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

    The MIL Network

  • MIL-OSI: Castellum, Inc. Announces Creation of New Subsidiary to Focus on Advanced Technology Products

    Source: GlobeNewswire (MIL-OSI)

    VIENNA, Va., June 24, 2025 (GLOBE NEWSWIRE) — Castellum, Inc. (the “Company” and “Castellum”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services and solutions company focused on the federal government, today announced the creation of a new wholly owned subsidiary, Castellum Advanced Technology Products, Inc. (“CATP”).

    CATP will focus on teaming with other leading-edge technology companies, developing technology internally, and potentially taking equity positions in companies that have advanced technology, which Castellum’s Department of Defense customers could use.

    “Fully and timely leveraging advanced technology is the key to success on the 21st-century battlefield,” said Glen Ives, Chief Executive Officer of Castellum. “While we will continue to provide technology-enabled services to our government clients, today’s announcement represents a meaningful broadening of Castellum’s strategy for supporting the Department of Defense. We believe that having greater control over some of the key products our customers need will enable us to provide better overall solutions for the warfighter. Financially, we believe that we can increase both our revenue and our operating margins by adding more value and solving our customers’ most challenging problems. This important step reinforces our priority, focus, and commitment to constantly strengthen and enhance our organic growth capabilities.”

    About Castellum, Inc. (NYSE-American: CTM):

    Castellum, Inc. (NYSE-American: CTM) is a cybersecurity, electronic warfare, and software engineering services company focused on the federal government – https://castellumus.com/.

    Forward-Looking Statements:

    This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Words such as “will,” “would,” “believe,” and “expects,” and similar language or phrasing are indicative of forward-looking statements. These forward-looking statements are subject to risks, uncertainties, and other factors, many of which are outside of the Company’s control, that could cause actual results to differ (sometimes materially) from the results expressed or implied in the forward-looking statements, including, among others: the Company’s ability to effectively integrate and grow its acquired companies; its ability to identify additional acquisition targets and close additional acquisitions; the impact on the Company’s revenue due to a delay in the U.S. Congress approving a federal budget, operating under a prolonged continuing resolution, government shutdown, or breach of the debt ceiling, as well as the imposition by the U.S. government of sequestration in the absence of an approved budget; the ability of the U.S. federal government to unilaterally cancel a contract with or without cause, and more specifically, the potential impact of the U.S. DOGE Service Temporary Organization on government spending and terminating contracts for convenience. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in Item 1A. “Risk Factors” section of the Company’s recently filed Form 10-Q, Item 1A. “Risk Factors” in the Company’s most recent Form 10-K, and other filings with the Securities and Exchange Commission which can be viewed at www.sec.gov. These risks and uncertainties, or not closing the described potential equity financing in this press release, could cause the Company’s actual results to differ materially from those indicated in the forward-looking statements. Except to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise.

    Contact:

    Glen Ives
    President and Chief Executive Officer
    Phone: (703) 752-6157
    info@castellumus.com
    https://castellumus.com

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/12cff6dc-d18b-4810-9020-5e7bab268788

    The MIL Network

  • MIL-OSI: RentRedi Survey: Smaller Landlords 60% More Likely to Enforce Renters Insurance

    Source: GlobeNewswire (MIL-OSI)

    NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) — A new joint survey from RentRedi, the fastest-growing landlord software that makes renting easy for everyone, and BiggerPockets, the largest online community for real estate investors, reveals that while most landlords understand the difference between renters insurance and landlord insurance, many still don’t require it—and even fewer take steps to verify it. These results, together with a companion survey conducted by RentRedi alone, highlight that many real estate investors are still exploring the best ways to implement and manage renters insurance within their rental process.

    The joint survey with BiggerPockets, conducted from June 11–16, 2025, gathered responses from 812 real estate investors and property owners. When asked how they verify renters insurance coverage, half of respondents reported that they currently do not verify whether their tenants have renters insurance. The rest rely on a mix of manual checks, insurance company confirmations, or property management software, demonstrating that many landlords are still exploring the best ways to integrate renters insurance into their rental process.

    This snapshot complements a broader RentRedi survey conducted from March 30 to April 14, 2025 with 1,623 respondents that analyzes landlord behavior across portfolio sizes. The data shows that more than three-fourths of landlords understand the difference between landlord and renters insurance. However, only about one in five landlords offer renters insurance options directly to tenants, and fewer than half include renters insurance as a requirement in the lease.

    Verification and enforcement also vary widely. Roughly four in ten landlords said they follow up to confirm tenants have active coverage, and among those who include a requirement in the lease, the majority—nearly three out of four—said they enforce it. These numbers reflect a growing interest in formalizing and standardizing renters insurance policies as landlords seek to reduce risk and increase protection for both themselves and their tenants.

    Interestingly, landlords with smaller portfolios (1–4 units) were more likely to require and enforce renters insurance. Nearly six in ten small landlords said they include renters insurance in the lease, and four out of five of those said they enforce that requirement. While larger portfolio landlords (20+ units) were less likely to include or enforce these requirements by 22 and 15 point margins respectively, they may benefit most from automation and integrated software solutions to help manage renters insurance at scale.

    “Renters insurance protects everyone involved. It minimizes financial risk, reduces liability, and gives both landlords and tenants greater peace of mind,” said RentRedi Co-founder and CEO Ryan Barone. “These results show that landlords recognize the value but often lack a streamlined way to implement it, and that’s exactly the problem that RentRedi solves.”

    With RentRedi, landlords can easily offer renters insurance options during the application and onboarding process, require proof of coverage within the lease, and automatically verify compliance. Tenants can purchase renters insurance directly through RentRedi’s app, or upload proof of an existing policy, and landlords are notified instantly. RentRedi also integrates with select providers to enable real-time tracking and add landlords as additional insured when needed. The result is a simpler, smarter way for landlords to protect their investments, while also delivering a better experience for tenants.

    In both surveys, percentages have been rounded to the nearest whole number. The full survey results can be found here. This report is part of RentRedi’s ongoing initiative to surface real-world insights from landlords and property managers through data, direct surveys, and collaborations with trusted communities like BiggerPockets. For more data insight and survey result reports, visit RentRedi’s Rental Market Insights.

    About RentRedi

    RentRedi offers an award-winning, comprehensive property management platform that simplifies the renting process for landlords and renters by automating and streamlining processes. Investors can quickly grow their rental businesses by using RentRedi’s all-in-one web and mobile app for rent collection, market listings, tenant screening, lease signing, maintenance coordination, and accounting. Tenants enjoy the convenience and benefits of RentRedi’s easy-to-use mobile app that allows them to pay rent, set up auto-pay, build credit by reporting rent payments to all three major credit bureaus, prequalify and sign leases, and submit 24/7 maintenance requests.

    Founded in 2016, RentRedi is VC-backed and a proven leader in the PropTech market. The company ranks No. 180 on the Inc. 5000 list and No. 13 on the Inc. 5000 Regionals list. It was also named an Inc. Power Partner in 2023 and 2024, and to Fast Company’s Next Big Things in Tech list in 2024, as well as HousingWire’s Tech100 list in 2025. To date, RentRedi has more than $28 billion in assets under management with nearly 200,000 landlords and tenants using its platform. The company partners with technology leaders such as Zillow, TransUnion, Experian, Equifax, Realtor.com, Lessen, Thumbtack, Plaid, and Stripe to create the best customer experience possible. For more information visit RentRedi.com.

    Photos accompanying this announcement are available at

    https://www.globenewswire.com/NewsRoom/AttachmentNg/3054c495-1990-46b7-b58b-45792a65b570

    https://www.globenewswire.com/NewsRoom/AttachmentNg/148eb0b8-2512-4a3c-82e4-3f6af3bb3394

    The MIL Network

  • MIL-OSI Africa: Eritrea: Diaspora Nationals Commemorate Martyrs Day


    Download logo

    Eritrean nationals in Switzerland, Saudi Arabia, United Arab Emirates, Sweden, the United States, Russian Federation, South Sudan, Austria, and Finland have commemorated Martyrs Day with pride.

    Eritrean communities in the Swiss cities of Geneva, Lausanne, Valais, Bern, Zurich, Chur, St. Gallen, Solothurn, Basel, Zug, Lucerne, Schaffhausen, and Ticino; Abu Dhabi and its environs in the UAE; Gothenburg, Sweden; Ohio, USA; Moscow, Russian Federation; Vienna, Austria; Aweil and Wau, South Sudan; as well as the Finnish cities of Helsinki, Jyvaskyla, Lahti, and Oulu commemorated Martyrs Day with patriotic zeal. Participants pledged to strengthen their engagement in supporting the Martyrs Trust Fund and the families of martyrs.

    Nationals in Aweil, South Sudan, assumed responsibility for supporting 130 families of martyrs and contributed 3,500 US dollars. Nationals in Abu Dhabi and its environs contributed 5,150 Dirhams, while nationals in Finland contributed 2,830 Euros toward augmenting the Martyrs Trust Fund.

    Nationals in Switzerland who had previously taken on the responsibility of supporting families of martyrs reaffirmed their commitment. Nationals in Canton Geneva and Canton Bern contributed 4,184 Swiss francs; Canton Schaffhausen, 1,320 Swiss francs; Canton St. Gallen, 2,920 Swiss francs; Canton Lausanne, 3,360 Swiss francs; Canton Lucerne, 5,000 Swiss francs; Canton Zurich, 5,565 Swiss francs; Canton Valais, 515 Swiss francs; and Canton Aargau, 500 Swiss francs. The Eritrean community in Biel/Bienne contributed 10,000 Swiss francs to the Martyrs Trust Fund.

    Similarly, nationals in Bern contributed 5,000 Swiss francs in support of seven families of martyrs; nationals in Graubünden contributed 3,600 Swiss francs for five families; and nationals in St. Gallen contributed 10,800 Swiss francs in support of 15 families of martyrs.

    Likewise, nationals residing in Dammam, Saudi Arabia, have pledged to assume responsibility for supporting 11 families of martyrs.

    Events in all cities featured candlelight vigils and walkathon programs.

    In related news, 114,000 Nakfa contributed by staff members of the Northern Red Sea Region administration and Foro sub-zone has been distributed to families of martyrs.

    Distributed by APO Group on behalf of Ministry of Information, Eritrea.

    MIL OSI Africa

  • MIL-OSI Africa: Mozambique: Armed Group’s Child Abductions Surge in North


    Download logo

    An armed group linked to the Islamic State (ISIS) has ramped up abductions of children in northern Mozambique’s Cabo Delgado province, Human Rights Watch said today. Most of the abducted children are being used for transporting looted goods, forced labor, forced marriages, and taking part in the fighting.

    National civil society groups and the United Nations Children’s Fund (UNICEF) report that such kidnappings are on the rise. While the armed group, locally known as Al-Shabab, released some of the children they abducted earlier this year, a number of children remain missing; those who have returned to their communities struggle with reintegration. 

    “The surge in abductions of children in Cabo Delgado adds to the horrors of Mozambique’s conflict,” said Ashwanee Budoo-Scholtz, deputy Africa director at Human Rights Watch. “Al-Shabab needs to spare children from the conflict and immediately release those who have been abducted.”

    In May and June 2025, Human Rights Watch interviewed nine people in Mozambique, including residents of Cabo Delgado, journalists, civil society activists, and a UN official, all of whom expressed concern about the resurgence of kidnappings. “In recent days, 120 or more children have been abducted,” said Abudo Gafuro, executive director at Kwendeleya, a national organization that monitors attacks and provides support to victims. 

    On January 23, 2025, Al-Shabab attacked the village of Mumu, in Mocímboa da Praia district, and abducted four girls and three boys. During Al-Shabab’s subsequent retreat, two children were released, but five remain missing. In March, the armed group abducted six children in Chibau to carry looted goods; four were released the following day. On May 3, Al-Shabab abducted a girl in the village of Ntotwe, Mocímboa da Praia district; on May 11, they kidnapped six girls and two boys near Magaia village in Muidumbe district. 

    When Al-Shabab fighters “enter or attack certain areas, they tend to abduct children,” said Augusta Iaquite, coordinator at the Association of Women in Legal Careers in Cabo Delgado. “They take them to train them and later turn them into their own fighters.” 

    When children who have been abducted return to the community, there are few resources to help them reintegrate, Human Rights Watch said. “The country needs a clear strategy on what to do when a child, especially one that has been rescued, returns,” said Benilde Nhalivilo, executive director at the Civil Society Forum for Children’s Rights. 

    Civil society organizations have called on Mozambique’s government to fulfill the country’s obligations under domestic and international law to protect the nation’s children. 

    Mozambique’s Constitution and the 2008 Law for the Promotion and Protection of Children’s Rights enshrine the state’s duty to protect children from all forms of violence, exploitation, and abuse. Additionally, Mozambique is a party to various international and regional instruments that guarantee children’s rights, including the UN Convention on the Rights of the Child and the African Charter on the Rights and Welfare of the Child. Both explicitly prohibit the abduction, recruitment, and exploitation of children. The UN Optional Protocol to the Child Rights Convention on the involvement of children in armed conflict, ratified by Mozambique in 2004, prohibits non-state armed groups from recruiting or using children under 18. 

    Under customary international humanitarian law and the Rome Statute of the International Criminal Court, children are entitled to special respect and protection, and recruiting or using children under the age of 15 to participate actively in hostilities is a war crime. 

    Mozambican authorities should seek to prevent further abductions, investigate existing cases and fairly prosecute those responsible, and ensure proper support for victims, Human Rights Watch said. Rescued children need medical care, psychosocial assistance, and reintegration mechanisms that provide for their protection and well-being.

    “Mozambique’s government needs to take concrete actions to safeguard children and prevent armed groups from using them as tools of conflict,” Budoo-Scholtz said. “There is a need to ensure that there are robust reintegration measures so that the children are not further ostracized when they come back to the community.”

    Distributed by APO Group on behalf of Human Rights Watch (HRW).

    MIL OSI Africa

  • MIL-OSI Africa: Expanding access to sexual and reproductive health services in Ethiopia


    Download logo

    To address gaps in sexual and reproductive healthcare access, widened by the COVID-19 pandemic and ongoing humanitarian crises, Ethiopia is reinforcing its health system, making these vital services more accessible for women and adolescents in remote and crisis-affected areas.

    A key part of this effort is promoting self-care, by giving people the knowledge and tools to manage their own sexual and reproductive health through safe, simple and affordable practices for family planning, HIV prevention, cervical cancer prevention, nutrition, and maternal, adolescent and youth health. Practical examples range from access to contraceptives, pregnancy tests, and HIV self-test kits, all supported by educational guidance. This also includes self-management of medical abortion in line with national legislation, which permits the procedure under certain conditions.  

    With support from World Health Organization (WHO), health authorities have developed the National Self-Care Intervention Guideline, focusing on interventions for women, adolescent and child health. They have also integrated self-care and expanded sexual and reproductive health services into key national policy guidelines, including those related to family planning, safe abortion care, teenage pregnancy reduction, and sexual and reproductive health responses in humanitarian settings.

    Across the country, health workers are being trained to teach people how to promote these self-care tools. This started with a workshop for 38 public health officials from the Ministry of Health, Regional Health Bureaus and other institutions in June 2024. The initiative was then expanded to the sub-national level, equipping 67 health providers and managers with skills, in October 2024.  

    “The recommendations and action plan we developed will help us integrate self-care into our existing health services effectively,” said Daniel Nadew, Maternal Child Health desk team lead from Addis Ababa City Health Bureau.

    Following the scaling up self-care training, at Kolfe Health Centre in Addis Ababa, one of the pilot facilities, the introduction of self-care services contributed to a significant increase in access to services. In 2024, as part of the family planning service delivery, more than 800 women received over-the-counter combined oral contraceptives, compared with 280 in 2022.

    Additionally, 84 women were trained to self-administer a safe and effective injectable contraceptive, known as DMPA, and more than 1000 adolescents were provided condoms after training on correct use.

    Moreover, 50 women received self-management of medical abortion services, which included comprehensive training on how and when to use the medication, the correct dose, side effects, possible complications, and guidance on when to get medical help.

    “The self-care training has significantly improved my knowledge and skills in providing comprehensive family planning and abortion care. The practical sessions were particularly helpful, and I feel more confident in my ability to support women in my community,” said Fatima Belay*, a health worker from Addis Ababa.

    Belay * also highlighted the benefits of self-administered injectable contraceptives: “I appreciate the ease and convenience of the self-administering contraceptive, which I am able to use at home, at my usual workplace, or wherever I am.”

    Amid the humanitarian crises in the northern region of Amhara, WHO and the Ethiopian Public Health Institute trained 30 healthcare providers from 13 health facilities in conflict-affected districts on self-care intervention guidelines.

    Following the training, nine facilities provided onsite selfcare orientation for their staff which resulted in over 100 women and adolescents being educated on selfcare for family planning, antenatal care, pregnancy danger signs, nutrition, and safe abortion.  

    Gish Abay Health Centre empowered 120 adolescents with skills for correct condom use and provided safe abortion care for 35 adolescent girls. Tilili Health Centre broadened the scope of self-care to include HIV self-testing, breast self-examination, pregnancy self-testing, and condom and emergency contraceptive use.

    “These interventions significantly benefited the community and contributed to the efforts towards reducing preventable maternal and perinatal deaths. It will enable us to reach every mother, newborn, child, and adolescent in our community who are critically in need of health services,” said Nadew.

    “Ethiopia’s commitment for self-care integration is empowering individuals, especially women and adolescents, with the knowledge and tools for proactive health management, offering considerable community convenience and cost savings,” said Dr Owen Kaluwa, WHO Representative in Ethiopia. “WHO is proud to support this effort, which significantly improves health outcomes by expanding access to critical sexual and reproductive health services, particularly crucial in conflict-affected areas.”

    Distributed by APO Group on behalf of World Health Organization (WHO) – Ethiopia.

    MIL OSI Africa

  • MIL-OSI Europe: OSCE convenes high-level Annual Security Review Conference to address the current security situation in the region

    Source: Organization for Security and Co-operation in Europe – OSCE

    Headline: OSCE convenes high-level Annual Security Review Conference to address the current security situation in the region

    VIENNA, 24 JUNE 2025 – The Organization for Security and Co-operation in Europe (OSCE) will hold a two-day Annual Security Review Conference (ASRC) in Vienna on 25 and 26 June 2025.
    Organized this year by the Finnish 2025 OSCE Chairpersonship, the Conference will bring together diplomats and high-level officials from the capitals of the 57 OSCE participating States.
    On 25 June, the opening session will feature keynote remarks by OSCE Chairperson-in-Office, Finnish Minister for Foreign Affairs Elina Valtonen (remotely), OSCE Secretary General Feridun H. Sinirlioğlu, and the Under-Secretary of State for Foreign and Security Policy of Finland Outi Holopainen.
    Journalists are invited to follow the livestream of the keynote segment of the opening session, beginning at 11:30 on Wednesday, 25 June 2025: www.osce.org/live
    The ASRC is one of the OSCE’s main events for fostering dialogue on regional security challenges, providing an essential platform for comprehensive discussions on contemporary security threats facing Europe and the role of the OSCE in addressing them.

    MIL OSI Europe News